
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Incidence and risk factors of resistant Pseudomonas aeruginosa infections: a multicenter study in Lebanese tertiary hospitals - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152545E58AF31C430545E50010B257F3.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmcid">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366003/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="BMC Infectious Diseases">
<meta name="citation_title" content="Incidence and risk factors of resistant Pseudomonas aeruginosa infections: a multicenter study in Lebanese tertiary hospitals">
<meta name="citation_author" content="Rania Itani">
<meta name="citation_author_institution" content="Pharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, 11-5020, Riad El Solh, Beirut, 1107 2809 Lebanon">
<meta name="citation_author" content="Hani M J Khojah">
<meta name="citation_author_institution" content="Department of Pharmacy Practice, College of Pharmacy, Taibah University, Madinah, Kingdom of Saudi Arabia">
<meta name="citation_author" content="Patricia Shuhaiber">
<meta name="citation_author_institution" content="Pharmacy Department, Mount Lebanon Hospital Balamand University Medical Center, Hazmieh, Lebanon">
<meta name="citation_author" content="Hamza Raychouni">
<meta name="citation_author_institution" content="Intensive Care Unit, Anesthesia Department, Central Military Hospital, Military Healthcare, Lebanese Army, Beirut, Lebanon">
<meta name="citation_author_institution" content="Intensive Care Unit, Respiratory Care Department, American University of Beirut Medical Center, Beirut, Lebanon">
<meta name="citation_author_institution" content="Intensive Care Unit, Aboujaoudé Hospital, Maten, Jal el Dib, Lebanon">
<meta name="citation_author" content="Carole Dib">
<meta name="citation_author_institution" content="Pharmacy Department, Lebanese Hospital Geitaoui University Medical Center, Beirut, Lebanon">
<meta name="citation_author" content="Mariam Hassan">
<meta name="citation_author_institution" content="Emergency Department, Sahel General Hospital, Beirut, Lebanon">
<meta name="citation_author" content="Tareq L Mukattash">
<meta name="citation_author_institution" content="Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan">
<meta name="citation_author" content="Abdalla El-Lakany">
<meta name="citation_author_institution" content="Department of Pharmaceutical Sciences, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon">
<meta name="citation_author_institution" content="Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="25">
<meta name="citation_firstpage" content="1048">
<meta name="citation_doi" content="10.1186/s12879-025-11467-4">
<meta name="citation_pmid" content="40836228">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366003/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366003/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366003/pdf/12879_2025_Article_11467.pdf">
<meta name="description" content="The emergence of difficult-to-treat resistant (DTR) Pseudomonas aeruginosa infections poses a significant clinical challenge, characterized by limited treatment options, poor outcomes, and increased morbidity and mortality. DTR P. aeruginosa ...">
<meta name="og:title" content="Incidence and risk factors of resistant Pseudomonas aeruginosa infections: a multicenter study in Lebanese tertiary hospitals">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The emergence of difficult-to-treat resistant (DTR) Pseudomonas aeruginosa infections poses a significant clinical challenge, characterized by limited treatment options, poor outcomes, and increased morbidity and mortality. DTR P. aeruginosa ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366003/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12366003">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12879-025-11467-4"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12879_2025_Article_11467.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366003%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12366003/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12366003/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366003/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmcid.png" alt="BMC Infectious Diseases logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BMC Infectious Diseases" title="Link to BMC Infectious Diseases" shape="default" href="https://bmcinfectdis.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMC Infect Dis</button></div>. 2025 Aug 20;25:1048. doi: <a href="https://doi.org/10.1186/s12879-025-11467-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12879-025-11467-4</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMC%20Infect%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMC%20Infect%20Dis%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMC%20Infect%20Dis%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMC%20Infect%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Incidence and risk factors of resistant <em>Pseudomonas aeruginosa</em> infections: a multicenter study in Lebanese tertiary hospitals</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Itani%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Rania Itani</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Rania Itani</span></h3>
<div class="p">
<sup>1</sup>Pharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, 11-5020, Riad El Solh, Beirut, 1107 2809 Lebanon </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Itani%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rania Itani</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khojah%20HMJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Hani M J Khojah</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Hani M J Khojah</span></h3>
<div class="p">
<sup>2</sup>Department of Pharmacy Practice, College of Pharmacy, Taibah University, Madinah, Kingdom of Saudi Arabia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khojah%20HMJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Hani M J Khojah</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shuhaiber%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Patricia Shuhaiber</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Patricia Shuhaiber</span></h3>
<div class="p">
<sup>3</sup>Pharmacy Department, Mount Lebanon Hospital Balamand University Medical Center, Hazmieh, Lebanon </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shuhaiber%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Patricia Shuhaiber</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Raychouni%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Hamza Raychouni</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Hamza Raychouni</span></h3>
<div class="p">
<sup>4</sup>Intensive Care Unit, Anesthesia Department, Central Military Hospital, Military Healthcare, Lebanese Army, Beirut, Lebanon </div>
<div class="p">
<sup>5</sup>Intensive Care Unit, Respiratory Care Department, American University of Beirut Medical Center, Beirut, Lebanon </div>
<div class="p">
<sup>6</sup>Intensive Care Unit, Aboujaoudé Hospital, Maten, Jal el Dib, Lebanon </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Raychouni%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hamza Raychouni</span></a>
</div>
</div>
<sup>4,</sup><sup>5,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dib%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Carole Dib</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Carole Dib</span></h3>
<div class="p">
<sup>7</sup>Pharmacy Department, Lebanese Hospital Geitaoui University Medical Center, Beirut, Lebanon </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dib%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Carole Dib</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hassan%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Mariam Hassan</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Mariam Hassan</span></h3>
<div class="p">
<sup>8</sup>Emergency Department, Sahel General Hospital, Beirut, Lebanon </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hassan%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mariam Hassan</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mukattash%20TL%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Tareq L Mukattash</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Tareq L Mukattash</span></h3>
<div class="p">
<sup>9</sup>Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mukattash%20TL%22%5BAuthor%5D" class="usa-link"><span class="name western">Tareq L Mukattash</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22El-Lakany%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Abdalla El-Lakany</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Abdalla El-Lakany</span></h3>
<div class="p">
<sup>10</sup>Department of Pharmaceutical Sciences, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon </div>
<div class="p">
<sup>11</sup>Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22El-Lakany%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Abdalla El-Lakany</span></a>
</div>
</div>
<sup>10,</sup><sup>11</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Pharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, 11-5020, Riad El Solh, Beirut, 1107 2809 Lebanon </div>
<div id="Aff2">
<sup>2</sup>Department of Pharmacy Practice, College of Pharmacy, Taibah University, Madinah, Kingdom of Saudi Arabia </div>
<div id="Aff3">
<sup>3</sup>Pharmacy Department, Mount Lebanon Hospital Balamand University Medical Center, Hazmieh, Lebanon </div>
<div id="Aff4">
<sup>4</sup>Intensive Care Unit, Anesthesia Department, Central Military Hospital, Military Healthcare, Lebanese Army, Beirut, Lebanon </div>
<div id="Aff5">
<sup>5</sup>Intensive Care Unit, Respiratory Care Department, American University of Beirut Medical Center, Beirut, Lebanon </div>
<div id="Aff6">
<sup>6</sup>Intensive Care Unit, Aboujaoudé Hospital, Maten, Jal el Dib, Lebanon </div>
<div id="Aff7">
<sup>7</sup>Pharmacy Department, Lebanese Hospital Geitaoui University Medical Center, Beirut, Lebanon </div>
<div id="Aff8">
<sup>8</sup>Emergency Department, Sahel General Hospital, Beirut, Lebanon </div>
<div id="Aff9">
<sup>9</sup>Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan </div>
<div id="Aff10">
<sup>10</sup>Department of Pharmaceutical Sciences, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon </div>
<div id="Aff11">
<sup>11</sup>Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Aug 8; Accepted 2025 Jul 30; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12366003  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40836228/" class="usa-link">40836228</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">The emergence of difficult-to-treat resistant (DTR) <em>Pseudomonas aeruginosa</em> infections poses a significant clinical challenge, characterized by limited treatment options, poor outcomes, and increased morbidity and mortality. DTR <em>P. aeruginosa</em> isolates exhibit resistance to all first-line antibiotics, necessitating the use of less effective or more toxic alternatives. This study estimated the incidence of DTR <em>P. aeruginosa</em> infections in Lebanon and identified the associated risk factors.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">This retrospective observational study was conducted across four tertiary care centers in Beirut, Lebanon, over a three-year period from 2021 to 2023. Univariate and multivariate logistic regression analyses were performed to identify significant predictors associated with DTR <em>P. aeruginosa</em> infections.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">A total of 2,639 cases with positive <em>P. aeruginosa</em> isolates were initially screened, with 477 cases meeting the inclusion criteria for analysis. The mean age of the patients was 66.3 ± 17.8 years, and the mean Charlson Comorbidity Index was 4.46 ± 2.43. Nearly half of the infections were nosocomial (47.6%). The most common primary site of infection was the respiratory tract (38.8%), followed by skin and soft tissue (32.7%). The incidence of DTR <em>P. aeruginosa</em> was 15.3%, and the incidence of carbapenem-resistant <em>P. aeruginosa</em> (CRPA) was 29.9%. Binary logistic regression identified three main risk factors for DTR <em>P. aeruginosa</em> infection acquisition: infections occurring during the winter season (adjusted odds ratio [AOR] = 6.08, 95% CI = 2.75–16.13, <em>P</em> &lt; 0.01), intensive care unit stay (AOR = 2.52, 95% CI = 1.28–4.98, <em>P</em> &lt; 0.01), and infections originating from the respiratory tract (AOR = 2.49, 95% CI = 1.04–5.97, <em>P</em> = 0.04).</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par4">The incidence of DTR <em>P. aeruginosa</em> in Lebanese hospitals is substantial compared to global rates and poses a significant challenge to effective treatment. Urgent measures are required to prevent and mitigate the spread of DTR <em>P. aeruginosa</em> infections. Hospital-based antimicrobial stewardship and infection control programs need to be reinforced, and community-based initiatives should be implemented at the national level. Efforts to combat antimicrobial resistance must be supported by ongoing nationwide annual surveillance.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> <em>Pseudomonas aeruginosa</em>, Antimicrobial resistance, Susceptibility patterns, Risk factors, Antibiotics, Lebanon</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par5"><em>Pseudomonas aeruginosa</em>, a Gram-negative bacterium, is a prevalent cause of nosocomial infections and is associated with severe illness and high mortality rates, ranging from 10.5 to 71%, depending on the site of infection, patient comorbidities, and antimicrobial resistance profile [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. This global public health threat is further exacerbated by the pathogen’s intrinsic antibiotic resistance and its exceptional ability to develop complex resistance mechanisms, significantly limiting treatment options [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. The World Health Organization (WHO) has identified <em>P. aeruginosa</em>, a member of the ESKAPE group of high priority pathogens, as one of the leading drug-resistant bacteria in need of urgent research and the development of effective therapeutic interventions [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>].</p>
<p id="Par6">In addition to its clinical impact, infections caused by <em>P. aeruginosa</em> impose a substantial economic burden on healthcare systems. These infections are associated with prolonged hospital stays, increased need for intensive care unit (ICU) admission, a greater risk of treatment failure, and elevated hospital readmission rates [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>–<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. A recent study assessing the economic impact of <em>P. aeruginosa</em> infections revealed that patients infected with resistant strains, compared to those with susceptible isolates, experienced significantly worse outcomes. These included higher mortality (20% vs. 15.5%, <em>P</em> = 0.002), an average excess hospital stay of 6.7 days (<em>P</em> &lt; 0.001), an additional cost of approximately US$20,000 per case (<em>P</em> = 0.002), and an incremental net financial loss exceeding US$10,000 per patient, as well as higher 30-day readmission rate (16.2% vs. 11.1%, <em>P</em> = 0.006) [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>].</p>
<p id="Par7">Studies from Lebanese hospitals have shown that <em>P. aeruginosa</em> is a major contributor to hospital-acquired infections, accounting for 12% of all nosocomial infections [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>], and approximately 9.6% of Gram-negative bloodstream infections [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. It consistently ranks among the top three to four most common pathogens in ICU and hospital-acquired bloodstream infections [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>–<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>].</p>
<p id="Par8">Recent years have seen several proposed classifications for antibiotic resistance, with the system by Magiorakos et al. being the most widely adopted. This classification includes multidrug-resistance (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR), based on the number of antibiotic classes showing activity in vitro [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. Additionally, another classification system based on resistance to specific antibiotic classes such as fluoroquinolones, cephalosporins, and carbapenems, has been introduced [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>].</p>
<p id="Par9">While these systems are useful epidemiologically, they have been criticized for their limited practical application in clinical settings and weak prediction of patient outcomes, particularly in <em>P. aeruginosa</em> infections [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. For instance, the Magiorakos et al. classification requires resistance to only one agent per class and weighs all antibiotics equally, regardless of their efficacy and toxicity [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>–<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. Furthermore, while resistance to antibiotic classes such as carbapenems indicates limited treatment options, <em>P. aeruginosa</em> can still respond to antipseudomonal penicillins, extended-spectrum cephalosporins, and fluoroquinolones despite carbapenem resistance [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. A new classification, difficult-to-treat resistance (DTR), has been recently proposed, which focuses on non-susceptibility to all first-line antibiotics, including all β-lactams and fluoroquinolones, thus necessitating the use of less effective or more toxic alternatives [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>].</p>
<p id="Par10">Infections caused by MDR and DTR <em>P. aeruginosa</em> have been linked to a variety of clinical and patient-related risk factors. Previous studies have identified several predisposing factors, including prior use of broad-spectrum antibiotics, prior hospitalization or ICU stay, prolonged hospital stay, exposure to mechanical ventilation or vasopressor support, tracheostomy, prior surgery, and prior colonization/infection [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>–<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Additionally, underlying medical conditions such as uncontrolled type II diabetes mellitus, severe COPD, bronchiectasis, cystic fibrosis, a bedridden state, and renal failure are significant predictors for acquiring MDR <em>P. aeruginosa</em> infections [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>–<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Higher baseline illness severity has also been significantly associated with the acquisition of DTR Gram-negative pathogens [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>].</p>
<p id="Par11">Despite the rising concern over DTR <em>P. aeruginosa</em> due to its high resistance profile and significant impact on patient outcomes, there remains a notable research gap attributable to the limited number of well-designed global studies that investigated its incidence and associated predictors [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>–<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. This gap is particularly pronounced in the context of Lebanese hospitals, where the incidence and risk factors for DTR <em>P. aeruginosa</em> infections remain underexplored. To address this issue, the current study aimed to estimate the incidence of DTR <em>P. aeruginosa</em> infections in Lebanese hospitals and identify the associated risk factors.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Study design, population, and setting</h3>
<p id="Par12">This multicenter retrospective observational study was conducted among hospitalized patients who were infected with <em>P. aeruginosa</em>. The research was carried out at four tertiary care centers in Beirut, Lebanon, over a three-year period from January 1, 2021, to December 31, 2023.</p>
<p id="Par13">The study included hospitalized adult patients aged 18 years and older with a confirmed <em>P. aeruginosa</em> infection. Exclusion criteria comprised cases of colonization, incomplete medical records or missing clinical data, incomplete antimicrobial susceptibility testing (AST), and patients with polymicrobial infections or coinfections. For patients with recurrent infections, only the first episode was included to avoid overestimation and to allow for incidence calculation. To distinguish colonization from infection, the review relied on documented clinical assessments and physicians’ progress notes, which specifically classified the presence of <em>P. aeruginosa</em> as either colonization or infection. The decision to exclude polymicrobial and co-infections was made to ensure a more homogeneous study population, and reduce selection bias.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Data collection and classification criteria</h3>
<p id="Par14">Data collection was conducted by systematically reviewing medical records provided by the microbiology laboratories at the participating hospitals. These records pertained to patients who tested positive for <em>P. aeruginosa</em> clinical isolates during the study period. A standardized data collection form, developed by the study’s principal investigator after a thorough review of relevant literature, was used to record pertinent information [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>–<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. The form was divided into three main sections.</p>
<p id="Par15">The first section captured patient demographics and clinical data, such as sex, age, total duration of hospitalization, onset of infection, site of infection acquisition, and the hospital department where the infection was acquired (for nosocomial cases). The onset of infection was defined as the date when the culture that eventually grew <em>P. aeruginosa</em> was collected [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. Infections were classified as either community-acquired (onset of signs and symptoms before or within 48 h of admission), or nosocomial (hospital-acquired, with onset after 48 h of admission) [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Additionally, the length of stay prior to infection acquisition, defined as the period of hospitalization before the infection onset, was also noted [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. The isolation frequency was calculated for each season, classified as follows: winter (December, January, and February), spring (March, April, and May), summer (June, July, and August), and fall (September, October, and November) [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>].</p>
<p id="Par16">The second section documented the patient’s underlying medical conditions and potential risk factors. Additionally, the patient’s Charlson Comorbidity Index (CCI) score was calculated. The CCI is a widely used clinical tool that predicts long-term mortality risk based on the presence of multiple comorbidities, with higher scores indicating a greater risk of mortality [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>–<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Additional risk factors, such as prior hospitalization, antibiotic use, and exposure to chemotherapy within the three months preceding infection acquisition, were also recorded. Recent antibiotic use was defined as the administration of any systemic antibiotic for at least 72 h within the three months before infection onset [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. The use of glucocorticoids within the past month was documented if the patient received a daily dose of 10 mg or more of prednisolone (or equivalent) for over five consecutive days within the four weeks before infection onset [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. This section also noted any invasive medical procedures or surgeries performed within a month prior to infection onset [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>].</p>
<p id="Par17">The third section focused on microbiological data, including details about the type of specimen obtained, the date of specimen retrieval, the primary site of infection, and the AST results of the isolated pathogen. Based on the AST results, isolates were classified according to their phenotypic resistance profiles as either difficult-to-treat resistant (DTR) <em>P. aeruginosa</em> or non-DTR <em>P. aeruginosa</em>, and as carbapenem-<em>resistant P. aeruginosa</em> (CRPA) or carbapenem-sensitive <em>P. aeruginosa</em> (CSPA). DTR <em>P. aeruginosa</em> was defined as non-susceptibility (intermediate or resistant) to all of the following: carbapenems (imipenem-cilastatin and/or meropenem), extended-spectrum cephalosporins (ceftazidime and/or cefepime), and fluoroquinolones (ciprofloxacin and/or levofloxacin). Additional agents like piperacillin-tazobactam and aztreonam were also considered when results were reported [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. CRPA was defined as an isolate intermediate or resistant to meropenem and/or imipenem-cilastatin, whereas CSPA was defined as an isolate not resistant or intermediate to these antibiotics [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>].</p></section><section id="Sec5"><h3 class="pmc_sec_title">Microbiological identification</h3>
<p id="Par18">Microbiological identification and antibiotic susceptibility testing (AST) of <em>P. aeruginosa</em> isolates were performed in the microbiology labs of the four participating hospitals, each following their standard diagnostic protocols. At Hospitals 1 and 2, both identification and susceptibility testing were conducted using the VITEK 2 automated system (bioMérieux, Marcy-l’Étoile, France), which provides minimum inhibitory concentration (MIC) values for various antibiotics. In contrast, Hospitals 3 and 4 applied the Kirby-Bauer disk diffusion technique, adhering to the guidelines set by the Clinical and Laboratory Standards Institute (CLSI). The inhibition zones produced by the antibiotics were manually measured and subsequently validated with an automated zone reader (ADAGIO, Bio-Rad Laboratories, Hercules, CA, USA). The results from all hospitals were interpreted according to CLSI breakpoint criteria, classifying the isolates as susceptible, intermediate, or resistant [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>].</p></section><section id="Sec6"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par19">Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS<sup>®</sup>, IBM Corp., Armonk, NY, USA), version 24. Continuous variables were expressed as means with standard deviations (SDs), while categorical variables were reported as frequencies and their relative percentages. The associations between DTR <em>P. aeruginosa</em> and independent categorical variables were examined using Pearson’s χ2 test, whereas the associations between continuous variables and DTR <em>P. aeruginosa</em> were evaluated using the Mann-Whitney U test. Variables with a <em>P</em>-value of less than 0.2 in the univariate analysis were included in the multivariable model.</p>
<p id="Par20">The initial set of variables considered for inclusion were: season, site of infection acquisition (community-acquired versus nosocomial infection), ICU stay, chronic obstructive pulmonary disease, previous hospitalization within the last three months, previous antibiotics use within the last three months, length of hospital stay prior to infection acquisition, invasive procedures conducted within 30 days prior to infection acquisition, presence of a central venous line, and the physiological primary site of infection.</p>
<p id="Par21">To check for multicollinearity, variance inflation factors (VIFs) were calculated using a cut-off value of 10 used for exclusion. All variables had VIFs under 2.5, indicating no significant multicollinearity. Variables that were conceptually related were carefully evaluated for clinical relevance and their contribution to model performance. Based on this evaluation, ICU stay was retained due to its stronger association with patient outcomes, while the site of infection acquisition was excluded. Similarly, the central venous line variable was removed because of its overlap with the more comprehensive variable recent invasive procedures, which was retained.</p>
<p id="Par22">The final multivariable logistic regression model was developed using a stepwise backward selection approach. Variables were considered confounders and retained if their removal resulted in a change of 10% or more in the coefficient of a statistically significant predictor. Model fit was evaluated using the Hosmer-Lemeshow goodness-of-fit test. Adjusted odds ratios (AORs) with corresponding 95% confidence intervals (CIs) were reported. Results with a P-value of less than 0.05 were considered statistically significant.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Ethical considerations</h3>
<p id="Par23">The study was designed and executed in adherence to the World Medical Association Declaration of Helsinki guidelines [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. The study protocol was approved by the institutional review board (IRB) at Beirut Arab University (approval code: 2023-H-0089-P-R-0532). Furthermore, ethical approvals were obtained from the IRBs and ethical committees of the participating hospitals: first hospital (approval code: 2023-IRB-012), second hospital (approval code: 8785/AM/T/BDM/Classification 30350/1), third hospital (approval code: 6/2023), and fourth hospital (approval code: HOP-2023-006). Data collection involved a comprehensive review of de-identified and anonymized medical records, with no direct patient contact or follow-up. The IRBs and ethical committees of the participating hospitals granted a waiver for patient’s informed consent due to the study’s retrospective observational design, which involved data collection post-discharge and ensured that no patient identifiers were accessed. This approach preserved patient privacy and adhered to ethical standards for such observational research.</p></section></section><section id="Sec8"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec9"><h3 class="pmc_sec_title">Patient demographics and clinical data</h3>
<p id="Par24">A total of 2,639 cases with positive <em>P. aeruginosa</em> isolates were initially screened. Out of these, 2,162 cases were excluded because they did not meet the inclusion criteria. Consequently, 477 patients with <em>P. aeruginosa</em> infections were included in this study.</p>
<p id="Par25">The mean age of the patients was 66.32 ± 17.88 years, with an age range of 18 to 101 years (Table <a href="#Tab1" class="usa-link">1</a>). Approximately two-thirds of the patients were males (294, 61.6%). Nearly half of the infections were community-acquired (250, 52.4%), while the rest were nosocomial (227, 47.6%), primarily acquired in the ICU (118/227, 20%). The mean onset of nosocomial infection was 12.48 ± 5.38 days. More than one-fourth of the infections occurred during the fall season, accounting for 131 cases (27.4%).</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Patients’ demographics and clinical data (<em>N</em> = 477)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Information</th>
<th align="left" colspan="1" rowspan="1">
<em>n</em> (%)</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="2" rowspan="1">Sex</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Male</em>
</td>
<td align="left" colspan="1" rowspan="1">294 (61.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Female</em>
</td>
<td align="left" colspan="1" rowspan="1">183 (38.4)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Age (years)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> 18–50</em>
</td>
<td align="left" colspan="1" rowspan="1">74 (15.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> 50–64</em>
</td>
<td align="left" colspan="1" rowspan="1">107 (22.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> 65–74</em>
</td>
<td align="left" colspan="1" rowspan="1">124 (26.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> ≥ 75</em>
</td>
<td align="left" colspan="1" rowspan="1">172 (36.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Mean ± standard deviation: 66.32 ± 17.88 (Range: 18–101)</em>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Total duration of hospitalization</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Mean ± SD = 16.35 ± 12.5 (range = 3–76)</em>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Infection acquisition site</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Community-acquired</em>
</td>
<td align="left" colspan="1" rowspan="1">250 (52.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Nosocomial</em>
</td>
<td align="left" colspan="1" rowspan="1">227 (47.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Intensive care unit</td>
<td align="left" colspan="1" rowspan="1">118 (52.0)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Internal medicine/cardiac care unit</td>
<td align="left" colspan="1" rowspan="1">83 (36.6)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Surgery</td>
<td align="left" colspan="1" rowspan="1">18 (7.9)<sup>a</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Oncology</td>
<td align="left" colspan="1" rowspan="1">8 (3.5)<sup>a</sup>
</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Onset of nosocomial infection (days)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Mean ± SD = 12.48 ± 5.38 (range = 3–57)</em>
</td>
<td align="left" colspan="1" rowspan="1">114 (23.9)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Season of infection acquisition</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Winter</em>
</td>
<td align="left" colspan="1" rowspan="1">112 (23.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Spring</em>
</td>
<td align="left" colspan="1" rowspan="1">114 (23.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Summer</em>
</td>
<td align="left" colspan="1" rowspan="1">120 (25.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Fall</em>
</td>
<td align="left" colspan="1" rowspan="1">131 (27.4)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Underlying medical conditions<sup>b</sup>
</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Previously healthy</em>
</td>
<td align="left" colspan="1" rowspan="1">46 (9.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Hypertension</em>
</td>
<td align="left" colspan="1" rowspan="1">246 (51.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Type II diabetes mellitus</em>
</td>
<td align="left" colspan="1" rowspan="1">198 (41.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Coronary artery disease</em>
</td>
<td align="left" colspan="1" rowspan="1">146 (30.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Dyslipidemia</em>
</td>
<td align="left" colspan="1" rowspan="1">108 (22.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Chronic obstructive pulmonary disease</em>
</td>
<td align="left" colspan="1" rowspan="1">74 (15.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Chronic kidney disease</em>
</td>
<td align="left" colspan="1" rowspan="1">58 (12.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Cancer/solid tumor (localized)</em>
</td>
<td align="left" colspan="1" rowspan="1">57 (11.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Congestive heart failure</em>
</td>
<td align="left" colspan="1" rowspan="1">50 (10.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Benign prostatic hyperplasia</em>
</td>
<td align="left" colspan="1" rowspan="1">38 (8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Atrial fibrillation</em>
</td>
<td align="left" colspan="1" rowspan="1">34 (7.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Peripheral vascular disease</em>
</td>
<td align="left" colspan="1" rowspan="1">34 (7.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Cerebral vascular accident</em>
</td>
<td align="left" colspan="1" rowspan="1">32 (6.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Cancer/solid tumor (metastatic)</em>
</td>
<td align="left" colspan="1" rowspan="1">20 (4.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Trauma/injuries/burn</em>
</td>
<td align="left" colspan="1" rowspan="1">18 (3.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Dementia</em>
</td>
<td align="left" colspan="1" rowspan="1">18 (3.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Epilepsy</em>
</td>
<td align="left" colspan="1" rowspan="1">16 (3.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Neurological disorder/loss of consciousness</em>
</td>
<td align="left" colspan="1" rowspan="1">14 (2.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Hypothyroidism</em>
</td>
<td align="left" colspan="1" rowspan="1">12 (2.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Autoimmune disease (Crohn’s disease</em>,<em> rheumatoid arthritis</em>,<em> lupus)</em>
</td>
<td align="left" colspan="1" rowspan="1">10 (2.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Anemia</em>
</td>
<td align="left" colspan="1" rowspan="1">10 (2.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Venous thromboembolism</em>
</td>
<td align="left" colspan="1" rowspan="1">8 (1.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Osteoporosis</em>
</td>
<td align="left" colspan="1" rowspan="1">8 (1.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Chronic liver disease</em>
</td>
<td align="left" colspan="1" rowspan="1">6 (1.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Alzheimer’s disease</em>
</td>
<td align="left" colspan="1" rowspan="1">6 (1.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Leukemia</em>
</td>
<td align="left" colspan="1" rowspan="1">4 (0.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Parkinson’s disease</em>
</td>
<td align="left" colspan="1" rowspan="1">4 (0.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Hyperthyroidism</em>
</td>
<td align="left" colspan="1" rowspan="1">4 (0.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Osteoarthritis</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Gout</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Peptic ulcer disease</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Pulmonary fibrosis</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Hemiplegia</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Lymphoma</em>
</td>
<td align="left" colspan="1" rowspan="1">1 (0.2)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Charlson Comorbidity Index</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Mean ± SD = 4.46 ± 2.43 (range = 0–11)</em>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hospitalization within the last three months</td>
<td align="left" colspan="1" rowspan="1">106 (22.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Use of chemotherapy within the last three months</td>
<td align="left" colspan="1" rowspan="1">81 (17)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Use of glucocorticoids within the last four weeks</td>
<td align="left" colspan="1" rowspan="1">95 (19.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Use of antibiotics within the last three months</td>
<td align="left" colspan="1" rowspan="1">116 (24.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Levofloxacin</em>
</td>
<td align="left" colspan="1" rowspan="1">26 (22.4)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Piperacillin-tazobactam</em>
</td>
<td align="left" colspan="1" rowspan="1">24 (20.6)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Metronidazole</em>
</td>
<td align="left" colspan="1" rowspan="1">12 (10.3)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Clindamycin</em>
</td>
<td align="left" colspan="1" rowspan="1">10 (8.6)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Ciprofloxacin</em>
</td>
<td align="left" colspan="1" rowspan="1">10 (8.6)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Azithromycin</em>
</td>
<td align="left" colspan="1" rowspan="1">8 (6.9)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Ceftriaxone</em>
</td>
<td align="left" colspan="1" rowspan="1">8 (6.9)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Meropenem</em>
</td>
<td align="left" colspan="1" rowspan="1">8 (6.9)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Tigecycline</em>
</td>
<td align="left" colspan="1" rowspan="1">6 (5.1)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Vancomycin</em>
</td>
<td align="left" colspan="1" rowspan="1">6 (5.1)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Amoxicillin-clavulanate</em>
</td>
<td align="left" colspan="1" rowspan="1">4 (3.4)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Amikacin</em>
</td>
<td align="left" colspan="1" rowspan="1">4 (3.4)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Cefixime</em>
</td>
<td align="left" colspan="1" rowspan="1">4 (3.4)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Linezolid</em>
</td>
<td align="left" colspan="1" rowspan="1">4 (3.4)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Rifaximin</em>
</td>
<td align="left" colspan="1" rowspan="1">4 (3.4)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Colistin</em>
</td>
<td align="left" colspan="1" rowspan="1">4 (3.4)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Rifampin</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (1.7)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Ertapenem</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (1.7)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Moxifloxacin</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (1.7)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Trimethoprim-sulfamethoxazole</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (1.7)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Imipenem-cilastatin</em>
</td>
<td align="left" colspan="1" rowspan="1">1 (0.8)<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Doxycycline</em>
</td>
<td align="left" colspan="1" rowspan="1">1 (0.8)<sup>c</sup>
</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Invasive medical procedures within 30 days prior to infection acquisition</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Mechanical ventilation</em>
</td>
<td align="left" colspan="1" rowspan="1">56 (11.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Indwelling urethral catheterization</em>
</td>
<td align="left" colspan="1" rowspan="1">54 (11.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Surgery within 30 days before hospitalization</em>
</td>
<td align="left" colspan="1" rowspan="1">34 (7.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Central venous line</em>
</td>
<td align="left" colspan="1" rowspan="1">28 (5.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Percutaneous endoscopic gastrostomy</em>
</td>
<td align="left" colspan="1" rowspan="1">16 (3.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Nasogastric tube</em>
</td>
<td align="left" colspan="1" rowspan="1">12 (2.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Tracheostomy</em>
</td>
<td align="left" colspan="1" rowspan="1">12 (2.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Renal replacement therapy (dialysis)</em>
</td>
<td align="left" colspan="1" rowspan="1">10 (2.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Prolonged total parenteral nutrition</em>
</td>
<td align="left" colspan="1" rowspan="1">8 (1.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Peripherally inserted central catheter line</em>
</td>
<td align="left" colspan="1" rowspan="1">8 (1.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Endoscopy</em>
</td>
<td align="left" colspan="1" rowspan="1">8 (1.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Ureteral stenting (double J stent)</em>
</td>
<td align="left" colspan="1" rowspan="1">6 (1.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Laryngoscope</em>
</td>
<td align="left" colspan="1" rowspan="1">4 (0.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Bronchoscopy</em>
</td>
<td align="left" colspan="1" rowspan="1">4 (0.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Percutaneous drainage</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Biliary drainage</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em> Uroscopy</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p28">
<p><em>SD</em> standard deviation</p>
<p><sup>a</sup>Percentage out of the 227 nosocomial cases</p>
<p><sup>b</sup>The total of 477 is not reflected in the numbers due to some patients having multiple responses recorded</p>
<p><sup>c</sup>Percentage out of the 116 patients who used antibiotics within the last three months</p>
</div></div></section><p id="Par27">Most patients had coexisting medical conditions (431, 90.4%), with the most common being hypertension (246, 51.6%), type II diabetes mellitus (198, 41.5%), and coronary artery disease (146, 30.6%) (Table <a href="#Tab1" class="usa-link">1</a>). The mean Charlson Comorbidity Index (CCI) was 4.46 ± 2.43, ranging from 0 to 11. Less than one-fourth of the patients had been hospitalized within three months prior to infection acquisition, while one-quarter had received antibiotics in the last three months preceding the infection (116, 24.3%). Additionally, one-third of the patients were exposed to invasive medical procedures before acquiring the infection (164, 34.5%), including mechanical ventilation (56, 11.7%), indwelling urethral catheterization (54, 11.3%), surgery (34, 7.1%), and central venous line placement (28, 5.9%).</p></section><section id="Sec10"><h3 class="pmc_sec_title">Microbiological characteristics and antimicrobial resistance patterns of <em>P. aeruginosa</em> isolates</h3>
<p id="Par28">The <em>P. aeruginosa</em> isolates were retrieved from various specimens, including skin (164, 34.4%), sputum (108, 22.6%), urine (98, 20.5%), deep tracheal aspirate (67, 14%), blood (18, 3.8%), bronchial aspirate (8, 1.7%), bile fluid (4, 0.8%), abdominal abscess (4, 0.8%), bone (2, 0.4%), gallbladder fluid (2, 0.4%), and broncho-alveolar lavage (2, 0.4%). The most common primary site of infection was the respiratory tract (185, 38.8%), followed by skin and soft tissue (156, 32.7%), urinary tract (98, 20.5%), bloodstream (18, 3.8%), intra-abdominal (10, 2.1%), surgical site (8, 1.7%), and bone (2, 0.4%).</p>
<p id="Par29">Table <a href="#Tab2" class="usa-link">2</a> presents the antimicrobial susceptibility results of the isolates. Resistance was lowest to colistin (0.9%), tobramycin (8.4%), and amikacin (10.1%). Higher resistance rates were noted for meropenem (27.5%), imipenem (24.4%), aztreonam (22.7%), and ciprofloxacin (20.4%). Resistance to piperacillin-tazobactam (16.3%), ceftazidime (15.6%), and cefepime (11.8%) was also observed.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>In vitro antimicrobial susceptibility results for <em>P. aeruginosa</em> isolates (<em>N</em> = 477)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Antibiotics</th>
<th align="left" colspan="1" rowspan="1">Isolates<sup>a</sup> (<em>n</em>)</th>
<th align="left" colspan="1" rowspan="1">Sensitive <em>n</em> (%)</th>
<th align="left" colspan="1" rowspan="1">Resistant <em>n</em> (%)</th>
<th align="left" colspan="1" rowspan="1">Intermediate <em>n</em> (%)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Amikacin</td>
<td align="left" colspan="1" rowspan="1">467</td>
<td align="left" colspan="1" rowspan="1">420 (89.9)</td>
<td align="left" colspan="1" rowspan="1">43 (9)</td>
<td align="left" colspan="1" rowspan="1">4 (0.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Aztreonam</td>
<td align="left" colspan="1" rowspan="1">132</td>
<td align="left" colspan="1" rowspan="1">94 (71.2)</td>
<td align="left" colspan="1" rowspan="1">30 (22.7)</td>
<td align="left" colspan="1" rowspan="1">8 (6.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cefepime</td>
<td align="left" colspan="1" rowspan="1">467</td>
<td align="left" colspan="1" rowspan="1">372 (79.7)</td>
<td align="left" colspan="1" rowspan="1">55 (11.8)</td>
<td align="left" colspan="1" rowspan="1">40 (8.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ceftazidime</td>
<td align="left" colspan="1" rowspan="1">469</td>
<td align="left" colspan="1" rowspan="1">366 (78)</td>
<td align="left" colspan="1" rowspan="1">73 (15.6)</td>
<td align="left" colspan="1" rowspan="1">30 (6.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ceftazidime-avibactam</td>
<td align="left" colspan="1" rowspan="1">28</td>
<td align="left" colspan="1" rowspan="1">18 (64.3)</td>
<td align="left" colspan="1" rowspan="1">10 (35.7)</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ceftolozane-tazobactam</td>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">6 (100)</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ciprofloxacin</td>
<td align="left" colspan="1" rowspan="1">471</td>
<td align="left" colspan="1" rowspan="1">340 (71.3)</td>
<td align="left" colspan="1" rowspan="1">96 (20.4)</td>
<td align="left" colspan="1" rowspan="1">35 (7.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Colistin</td>
<td align="left" colspan="1" rowspan="1">447</td>
<td align="left" colspan="1" rowspan="1">443 (99.1)</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fosfomycin</td>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
<td align="left" colspan="1" rowspan="1">8 (100)</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gentamicin</td>
<td align="left" colspan="1" rowspan="1">447</td>
<td align="left" colspan="1" rowspan="1">390 (87.2)</td>
<td align="left" colspan="1" rowspan="1">34 (7.6)</td>
<td align="left" colspan="1" rowspan="1">23 (5.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Imipenem</td>
<td align="left" colspan="1" rowspan="1">463</td>
<td align="left" colspan="1" rowspan="1">326 (70.4)</td>
<td align="left" colspan="1" rowspan="1">113 (24.4)</td>
<td align="left" colspan="1" rowspan="1">24 (5.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Levofloxacin</td>
<td align="left" colspan="1" rowspan="1">34</td>
<td align="left" colspan="1" rowspan="1">20 (58.8)</td>
<td align="left" colspan="1" rowspan="1">12 (35.3)</td>
<td align="left" colspan="1" rowspan="1">2 (5.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Meropenem</td>
<td align="left" colspan="1" rowspan="1">353</td>
<td align="left" colspan="1" rowspan="1">240 (68)</td>
<td align="left" colspan="1" rowspan="1">97 (27.5)</td>
<td align="left" colspan="1" rowspan="1">16 (4.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Minocycline</td>
<td align="left" colspan="1" rowspan="1">200</td>
<td align="left" colspan="1" rowspan="1">2 (1)</td>
<td align="left" colspan="1" rowspan="1">198 (99)</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Norfloxacin</td>
<td align="left" colspan="1" rowspan="1">24</td>
<td align="left" colspan="1" rowspan="1">18 (75)</td>
<td align="left" colspan="1" rowspan="1">6 (25)</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pefloxacin</td>
<td align="left" colspan="1" rowspan="1">203</td>
<td align="left" colspan="1" rowspan="1">130 (64)</td>
<td align="left" colspan="1" rowspan="1">53 (26.1)</td>
<td align="left" colspan="1" rowspan="1">20 (9.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Piperacillin</td>
<td align="left" colspan="1" rowspan="1">313</td>
<td align="left" colspan="1" rowspan="1">214 (68.4)</td>
<td align="left" colspan="1" rowspan="1">59 (18.8)</td>
<td align="left" colspan="1" rowspan="1">40 (12.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Piperacillin-tazobactam</td>
<td align="left" colspan="1" rowspan="1">471</td>
<td align="left" colspan="1" rowspan="1">340 (72.2)</td>
<td align="left" colspan="1" rowspan="1">77 (16.3)</td>
<td align="left" colspan="1" rowspan="1">54 (11.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Prulifloxacin</td>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">6 (100)</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ticarcillin</td>
<td align="left" colspan="1" rowspan="1">199</td>
<td align="left" colspan="1" rowspan="1">104 (52.3)</td>
<td align="left" colspan="1" rowspan="1">65 (32.7)</td>
<td align="left" colspan="1" rowspan="1">30 (15.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ticarcillin-clavulanate</td>
<td align="left" colspan="1" rowspan="1">211</td>
<td align="left" colspan="1" rowspan="1">108 (51.2)</td>
<td align="left" colspan="1" rowspan="1">63 (29.9)</td>
<td align="left" colspan="1" rowspan="1">40 (19)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tigecycline</td>
<td align="left" colspan="1" rowspan="1">10</td>
<td align="left" colspan="1" rowspan="1">4 (40)</td>
<td align="left" colspan="1" rowspan="1">6 (60)</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tobramycin</td>
<td align="left" colspan="1" rowspan="1">332</td>
<td align="left" colspan="1" rowspan="1">305 (91.6)</td>
<td align="left" colspan="1" rowspan="1">26 (7.8)</td>
<td align="left" colspan="1" rowspan="1">2 (0.6)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p38"><p><sup>a</sup>Number of isolates tested with each antibiotic</p></div></div></section><p id="Par30">The CRPA rate was 29.9%. Notably, almost half of the isolates were AMR (221, 46.3%), with 29.8% being MDR and 16.6% XDR‎. None of the isolates were PDR. The incidence of DTR was 15.3%.</p></section><section id="Sec11"><h3 class="pmc_sec_title">Risk factors associated with the acquisition of difficult-to-treat resistant <em>P. aeruginosa</em> infection</h3>
<p id="Par32">Table <a href="#Tab3" class="usa-link">3</a> presents the univariate analysis of the potential risk factors associated with the acquisition of DTR <em>P. aeruginosa</em> infection. The analysis identified nine significant risk factors. <em>P. aeruginosa</em> isolates acquired from the ICU ‎were significantly more likely to be DTR compared to other settings (unadjusted odds ratio [UOR] = 3.32, 95% CI = 1.98–5.58, <em>P</em> &lt; 0.001). Patients with chronic obstructive pulmonary disease (COPD) had twice the odds of acquiring a DTR infection (UOR = 2.03, 95% CI = 1.11–3.71, <em>P</em> = 0.01). Additionally, patients who were previously hospitalized (UOR = 3.48, 95% CI = 2.06–5.89, <em>P</em> &lt; 0.001) and those who received antibiotics within the three months prior to infection acquisition (UOR = 2.23, 95% CI = 1.32–3.79, <em>P</em> &lt; 0.01) were more likely to acquire a DTR pathogen. Nosocomial infections were more likely associated with DTR strains than community-acquired infections (UOR = ‎3.50, 95% CI = 2.02–6.08, <em>P</em> &lt; 0.001). A longer hospital stay prior to infection acquisition was also a significant predictor for acquiring a DTR infection (<em>P</em> = 0.03). Furthermore, exposure to invasive medical procedures (UOR = 2.10, 95% CI = 1.27–3.47, <em>P</em> &lt; 0.01), including the insertion of a central venous line (UOR = 2.36, 95% CI = 1.05–5.59, <em>P</em> = 0.04), significantly increased the risk of acquiring a DTR <em>P. aeruginosa</em> infection.</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Univariate analysis of predictors associated with the acquisition of difficult-to-treat resistant <em>P. aeruginosa</em> (<em>N</em> = 477)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Characteristics</th>
<th align="left" rowspan="2" colspan="1">
<em>n</em> (%)<sup>a</sup>
</th>
<th align="left" colspan="2" rowspan="1">
<em>P</em>. aeruginosa</th>
<th align="left" rowspan="2" colspan="1">UOR (95% CI)</th>
<th align="left" rowspan="2" colspan="1">Pearson’s 𝑋<sup>2</sup>
</th>
<th align="left" rowspan="2" colspan="1">
<em>P</em>
<sup>c</sup>
</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Non-DTR (<em>N</em> = 404) <em>n</em> (%)<sup>b</sup>
</th>
<th align="left" colspan="1" rowspan="1">DTR (<em>N</em> = 73) <em>n</em> (%)<sup>b</sup>
</th>
</tr>
</thead>
<tbody>
<tr><td align="left" colspan="7" rowspan="1">Season<sup>†</sup> (reference: spring)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Winter</td>
<td align="left" colspan="1" rowspan="1">112 (23.5)</td>
<td align="left" colspan="1" rowspan="1">86 (76.8)</td>
<td align="left" colspan="1" rowspan="1">26 (23.2)</td>
<td align="left" colspan="1" rowspan="1">4.01 (1.73–9.3)</td>
<td align="left" rowspan="4" colspan="1">11.50</td>
<td align="left" rowspan="4" colspan="1">&lt; 0.001<sup>d, e</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Spring</td>
<td align="left" colspan="1" rowspan="1">114 (23.9)</td>
<td align="left" colspan="1" rowspan="1">106 (93)</td>
<td align="left" colspan="1" rowspan="1">8 (7)</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Summer</td>
<td align="left" colspan="1" rowspan="1">120 (25.2)</td>
<td align="left" colspan="1" rowspan="1">102 (85)</td>
<td align="left" colspan="1" rowspan="1">18 (15)</td>
<td align="left" colspan="1" rowspan="1">2.34 (0.97–5.62)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Fall</td>
<td align="left" colspan="1" rowspan="1">131 (27.4)</td>
<td align="left" colspan="1" rowspan="1">110 (84)</td>
<td align="left" colspan="1" rowspan="1">21 (16)</td>
<td align="left" colspan="1" rowspan="1">2.53 (1.07–5.96)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Age group (reference: 18–64 years)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 18–64</td>
<td align="left" colspan="1" rowspan="1">181 (37.9)</td>
<td align="left" colspan="1" rowspan="1">144 (79.6)</td>
<td align="left" colspan="1" rowspan="1">37 (20.4)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" rowspan="2" colspan="1">5.94</td>
<td align="left" rowspan="2" colspan="1">0.09</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≥ 65</td>
<td align="left" colspan="1" rowspan="1">296 (62.1)</td>
<td align="left" colspan="1" rowspan="1">260 (87.8)</td>
<td align="left" colspan="1" rowspan="1">36 (12.2)</td>
<td align="left" colspan="1" rowspan="1">0.54 (0.33–0.89)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Sex (reference: female)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Male</td>
<td align="left" colspan="1" rowspan="1">294 (61.6)</td>
<td align="left" colspan="1" rowspan="1">256 (87.1)</td>
<td align="left" colspan="1" rowspan="1">38 (12.9)</td>
<td align="left" colspan="1" rowspan="1">0.63 (0.38–1.04)</td>
<td align="left" rowspan="2" colspan="1">3.34</td>
<td align="left" rowspan="2" colspan="1">0.06</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Female</td>
<td align="left" colspan="1" rowspan="1">183 (38.4)</td>
<td align="left" colspan="1" rowspan="1">148 (80.9)</td>
<td align="left" colspan="1" rowspan="1">35 (19.1)</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Site of infection acquisition (reference: community-acquired)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Community-acquired</td>
<td align="left" colspan="1" rowspan="1">250 (52.4)</td>
<td align="left" colspan="1" rowspan="1">230 (92)</td>
<td align="left" colspan="1" rowspan="1">20 (8)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" rowspan="2" colspan="1">21.62</td>
<td align="left" rowspan="2" colspan="1">&lt; 0.001<sup>d</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Nosocomial</td>
<td align="left" colspan="1" rowspan="1">227 (47.6)</td>
<td align="left" colspan="1" rowspan="1">174 (76.7)</td>
<td align="left" colspan="1" rowspan="1">53 (23.3)</td>
<td align="left" colspan="1" rowspan="1">3.50 (2.02–6.08)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Intensive care unit stay<sup>†</sup> (reference: no)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">359 (75.3)</td>
<td align="left" colspan="1" rowspan="1">320 (89.1)</td>
<td align="left" colspan="1" rowspan="1">39 (10.9)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" rowspan="2" colspan="1">22.07</td>
<td align="left" rowspan="2" colspan="1">&lt; 0.001<sup>d</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">118 (24.7)</td>
<td align="left" colspan="1" rowspan="1">84 (71.2)</td>
<td align="left" colspan="1" rowspan="1">34 (28.8)</td>
<td align="left" colspan="1" rowspan="1">3.32 (1.98–5.58)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Underlying medical conditions (reference: no history of the related condition)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hypertension</td>
<td align="left" colspan="1" rowspan="1">246 (51.6)</td>
<td align="left" colspan="1" rowspan="1">208 (84.6)</td>
<td align="left" colspan="1" rowspan="1">38 (15.4)</td>
<td align="left" colspan="1" rowspan="1">1.02 (0.62–1.68)</td>
<td align="left" colspan="1" rowspan="1">0.008</td>
<td align="left" colspan="1" rowspan="1">0.92</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Type II diabetes mellitus</td>
<td align="left" colspan="1" rowspan="1">198 (41.5)</td>
<td align="left" colspan="1" rowspan="1">164 (82.8)</td>
<td align="left" colspan="1" rowspan="1">34 (17.2)</td>
<td align="left" colspan="1" rowspan="1">1.28 (0.77–2.11)</td>
<td align="left" colspan="1" rowspan="1">0.91</td>
<td align="left" colspan="1" rowspan="1">0.34</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Coronary artery disease</td>
<td align="left" colspan="1" rowspan="1">146 (30.6)</td>
<td align="left" colspan="1" rowspan="1">122 (83.6)</td>
<td align="left" colspan="1" rowspan="1">24 (16.4)</td>
<td align="left" colspan="1" rowspan="1">1.13 (0.66–1.93)</td>
<td align="left" colspan="1" rowspan="1">0.20</td>
<td align="left" colspan="1" rowspan="1">0.64</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Dyslipidemia</td>
<td align="left" colspan="1" rowspan="1">108 (22.6)</td>
<td align="left" colspan="1" rowspan="1">90 (83.3)</td>
<td align="left" colspan="1" rowspan="1">18 (16.7)</td>
<td align="left" colspan="1" rowspan="1">1.14 (0.64–2.04)</td>
<td align="left" colspan="1" rowspan="1">0.20</td>
<td align="left" colspan="1" rowspan="1">0.65</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Chronic obstructive pulmonary disease<sup>†</sup>
</td>
<td align="left" colspan="1" rowspan="1">74 (15.5)</td>
<td align="left" colspan="1" rowspan="1">56 (75.7)</td>
<td align="left" colspan="1" rowspan="1">18 (24.3)</td>
<td align="left" colspan="1" rowspan="1">2.03 (1.11–3.71)</td>
<td align="left" colspan="1" rowspan="1">5.49</td>
<td align="left" colspan="1" rowspan="1">0.01<sup>d</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Chronic kidney disease</td>
<td align="left" colspan="1" rowspan="1">58 (12.2)</td>
<td align="left" colspan="1" rowspan="1">46 (79.3)</td>
<td align="left" colspan="1" rowspan="1">12 (20.7)</td>
<td align="left" colspan="1" rowspan="1">1.53 (0.77–3.06)</td>
<td align="left" colspan="1" rowspan="1">1.47</td>
<td align="left" colspan="1" rowspan="1">0.22</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Cancer/Solid tumor (localized)</td>
<td align="left" colspan="1" rowspan="1">57 (11.9)</td>
<td align="left" colspan="1" rowspan="1">50 (87.7)</td>
<td align="left" colspan="1" rowspan="1">7 (12.3)</td>
<td align="left" colspan="1" rowspan="1">0.75 (0.33–1.73)</td>
<td align="left" colspan="1" rowspan="1">0.45</td>
<td align="left" colspan="1" rowspan="1">0.50</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Congestive heart failure</td>
<td align="left" colspan="1" rowspan="1">50 (10.5)</td>
<td align="left" colspan="1" rowspan="1">42 (84)</td>
<td align="left" colspan="1" rowspan="1">8 (16)</td>
<td align="left" colspan="1" rowspan="1">1.06 (0.48–2.36)</td>
<td align="left" colspan="1" rowspan="1">0.02</td>
<td align="left" colspan="1" rowspan="1">0.88</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Charlson Comorbidity Index</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Mean ± SD</td>
<td align="left" colspan="1" rowspan="1">4.46 ± 2.43</td>
<td align="left" colspan="1" rowspan="1">4.47 ± 2.35</td>
<td align="left" colspan="1" rowspan="1">4.44 ± 2.82</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">0.78<sup>f</sup>
</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Previous hospitalization within the last three months<sup>†</sup> (reference: no)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">371 (77.8)</td>
<td align="left" colspan="1" rowspan="1">330 (88.9)</td>
<td align="left" colspan="1" rowspan="1">41 (11.1)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" rowspan="2" colspan="1">23.29</td>
<td align="left" rowspan="2" colspan="1">&lt; 0.001<sup>d</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">106 (22.2)</td>
<td align="left" colspan="1" rowspan="1">74 (69.8)</td>
<td align="left" colspan="1" rowspan="1">32 (30.2)</td>
<td align="left" colspan="1" rowspan="1">3.48 (2.06–5.89)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Previous antibiotics use within the last three months<sup>†</sup> (reference: no)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">361 (75.7)</td>
<td align="left" colspan="1" rowspan="1">316 (87.5)</td>
<td align="left" colspan="1" rowspan="1">45 (12.5)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" rowspan="2" colspan="1">9.22</td>
<td align="left" rowspan="2" colspan="1">0.002<sup>d</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">116 (24.3)</td>
<td align="left" colspan="1" rowspan="1">88 (75.9)</td>
<td align="left" colspan="1" rowspan="1">28 (24.1)</td>
<td align="left" colspan="1" rowspan="1">2.23 (1.32–3.79)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Previous glucocorticoids use within the last four weeks (reference: no)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">382 (80.1)</td>
<td align="left" colspan="1" rowspan="1">328 (85.9)</td>
<td align="left" colspan="1" rowspan="1">54 (14.1)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" rowspan="2" colspan="1">2.01</td>
<td align="left" rowspan="2" colspan="1">0.15</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">95 (19.9)</td>
<td align="left" colspan="1" rowspan="1">76 (80)</td>
<td align="left" colspan="1" rowspan="1">19 (20)</td>
<td align="left" colspan="1" rowspan="1">1.52 (0.85–2.71)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Previous chemotherapy use within the last three months (reference: no)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">396 (83)</td>
<td align="left" colspan="1" rowspan="1">334 (84.3)</td>
<td align="left" colspan="1" rowspan="1">62 (15.7)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" rowspan="2" colspan="1">0.22</td>
<td align="left" rowspan="2" colspan="1">0.63</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">81 (17)</td>
<td align="left" colspan="1" rowspan="1">70 (86.4)</td>
<td align="left" colspan="1" rowspan="1">11 (13.6)</td>
<td align="left" colspan="1" rowspan="1">0.85 (0.42–1.69)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Length of hospital stay prior to infection acquisition<sup>†</sup>
</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Mean ± SD (days)</td>
<td align="left" colspan="1" rowspan="1">12.42 ± 5.38</td>
<td align="left" colspan="1" rowspan="1">11.42 ± 5.26</td>
<td align="left" colspan="1" rowspan="1">15.37 ± 4.29</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">0.03<sup>d, g</sup>
</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Invasive procedures within 30 days prior to infection acquisition<sup>†</sup> (reference: no)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">313 (65.5)</td>
<td align="left" colspan="1" rowspan="1">276 (88.2)</td>
<td align="left" colspan="1" rowspan="1">37 (11.8)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" rowspan="2" colspan="1">8.52</td>
<td align="left" rowspan="2" colspan="1">0.004<sup>d</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">164 (34.5)</td>
<td align="left" colspan="1" rowspan="1">128 (78)</td>
<td align="left" colspan="1" rowspan="1">36 (22)</td>
<td align="left" colspan="1" rowspan="1">2.10 (1.27–3.47)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Mechanical ventilation (reference: no)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">421 (88.3)</td>
<td align="left" colspan="1" rowspan="1">358 (85)</td>
<td align="left" colspan="1" rowspan="1">63 (15)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" rowspan="2" colspan="1">0.31</td>
<td align="left" rowspan="2" colspan="1">0.57</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">56 (11.7)</td>
<td align="left" colspan="1" rowspan="1">46 (82.1)</td>
<td align="left" colspan="1" rowspan="1">10 (17.9)</td>
<td align="left" colspan="1" rowspan="1">1.24 (0.59–2.57)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Indwelling urethral catheterization (reference: no)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">423 (88.7)</td>
<td align="left" colspan="1" rowspan="1">362 (85.6)</td>
<td align="left" colspan="1" rowspan="1">61 (14.4)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" rowspan="2" colspan="1">2.24</td>
<td align="left" rowspan="2" colspan="1">0.13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">54 (11.3)</td>
<td align="left" colspan="1" rowspan="1">42 (77.8)</td>
<td align="left" colspan="1" rowspan="1">12 (22.2)</td>
<td align="left" colspan="1" rowspan="1">1.70 (0.84–3.40)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Central venous line (reference: no)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">449 (94.1)</td>
<td align="left" colspan="1" rowspan="1">384 (85.5)</td>
<td align="left" colspan="1" rowspan="1">65 (14.5)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" rowspan="2" colspan="1">4.04</td>
<td align="left" rowspan="2" colspan="1">0.04<sup>d</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">28 (5.9)</td>
<td align="left" colspan="1" rowspan="1">20 (71.4)</td>
<td align="left" colspan="1" rowspan="1">8 (28.6)</td>
<td align="left" colspan="1" rowspan="1">2.36 (1.0–5.59)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Major surgery (reference: no)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">443 (92.9)</td>
<td align="left" colspan="1" rowspan="1">376 (84.9)</td>
<td align="left" colspan="1" rowspan="1">67 (15.1)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" rowspan="2" colspan="1">0.15</td>
<td align="left" rowspan="2" colspan="1">0.69</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">34 (7.1)</td>
<td align="left" colspan="1" rowspan="1">28 (82.4)</td>
<td align="left" colspan="1" rowspan="1">6 (17.6)</td>
<td align="left" colspan="1" rowspan="1">1.20 (0.48–3.02)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Physiological primary site of infection<sup>†</sup> (reference: urinary tract)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Respiratory tract</td>
<td align="left" colspan="1" rowspan="1">185 (38.8)</td>
<td align="left" colspan="1" rowspan="1">142 (76.8)</td>
<td align="left" colspan="1" rowspan="1">43 (23.2)</td>
<td align="left" colspan="1" rowspan="1">2.66 (1.27–5.57)</td>
<td align="left" rowspan="7" colspan="1">24.42</td>
<td align="left" rowspan="7" colspan="1">0.001<sup>d, h</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Soft tissue/wound</td>
<td align="left" colspan="1" rowspan="1">156 (32.7)</td>
<td align="left" colspan="1" rowspan="1">144 (92.3)</td>
<td align="left" colspan="1" rowspan="1">12 (7.7)</td>
<td align="left" colspan="1" rowspan="1">0.73 (0.30–1.77)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Urinary tract</td>
<td align="left" colspan="1" rowspan="1">98 (20.5)</td>
<td align="left" colspan="1" rowspan="1">88 (89.8)</td>
<td align="left" colspan="1" rowspan="1">10 (10.2)</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Bloodstream</td>
<td align="left" colspan="1" rowspan="1">18 (3.8)</td>
<td align="left" colspan="1" rowspan="1">12 (66.7)</td>
<td align="left" colspan="1" rowspan="1">6 (33.3)</td>
<td align="left" colspan="1" rowspan="1">4.40 (1.35–14.29)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Intra-abdominal</td>
<td align="left" colspan="1" rowspan="1">10 (2.1)</td>
<td align="left" colspan="1" rowspan="1">8 (80)</td>
<td align="left" colspan="1" rowspan="1">2 (20)</td>
<td align="left" colspan="1" rowspan="1">2.20 (0.41–11.83)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Surgical site</td>
<td align="left" colspan="1" rowspan="1">8 (1.7)</td>
<td align="left" colspan="1" rowspan="1">8 (100)</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Bone</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
<td align="left" colspan="1" rowspan="1">2 (100)</td>
<td align="left" colspan="1" rowspan="1">0 (0)</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p42">
<p><em>CI</em> confidence interval, <em>DTR</em> <em>difficult-to-treat resistant</em>,<em> ICU</em> intensive care unit,<em> SD</em> standard deviation, <em>UOR</em> unadjusted odds ratio</p>
<p><sup>a</sup>Percentages for the column</p>
<p><sup>b</sup>Percentages for the row</p>
<p><sup>c</sup>Univariate analysis was conducted to test the associations between variables with DTR P. aeruginosa</p>
<p><sup>d</sup>Statistically significant (𝑃 &lt; 0.05)</p>
<p><sup>e</sup>The only significant difference was observed between the winter season and all other groups</p>
<p><sup>f</sup>Mann-Whitney U test was conducted to test the association between Charlson Comorbidity Index and DTR <em>P. aeruginosa</em></p>
<p><sup>g</sup>Mann-Whitney U test was conducted to test the association between the length of hospital stay prior to infection and DTR <em>P. aeruginosa</em></p>
<p><sup>h</sup>The only significant difference was observed between the respiratory tract and bloodstream infection and all other groups</p>
<p><sup>†</sup>Retained in the final model</p>
</div></div></section><p id="Par34">The binary logistic regression revealed three main risk factors significantly associated with the acquisition of DTR <em>P. aeruginosa</em> infection (Table <a href="#Tab4" class="usa-link">4</a>). Specifically, infections occurring during the winter season (adjusted odds ratio [AOR] = 6.08, 95% CI = 2.75–16.13, <em>P</em> &lt; 0.01), ICU stay (AOR = 2.52, 95% CI = 1.28–4.98, <em>P</em> &lt; 0.01), and infections originating from the respiratory tract (AOR = 2.49, 95% CI = 1.04–5.97, <em>P</em> = 0.04) were more likely to be associated with DTR <em>P. aeruginosa</em> acquisition.</p>
<section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Logistic regression analysis<sup>a</sup> of the significant predictors associated with the acquisition of difficult-to-treat resistant <em>P. aeruginosa</em> (<em>N</em> = 477)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Predictors</th>
<th align="left" colspan="1" rowspan="1">UOR</th>
<th align="left" colspan="1" rowspan="1">B</th>
<th align="left" colspan="1" rowspan="1">SE</th>
<th align="left" colspan="1" rowspan="1">Wald</th>
<th align="left" colspan="1" rowspan="1">AOR</th>
<th align="left" colspan="1" rowspan="1">95% CI</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em>
</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Constant</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">−2.38</td>
<td align="left" colspan="1" rowspan="1">0.67</td>
<td align="left" colspan="1" rowspan="1">12.69</td>
<td align="left" colspan="1" rowspan="1">0.09</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.001</td>
</tr>
<tr><td align="left" colspan="8" rowspan="1">Intensive care unit stay (reference: no)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">3.32</td>
<td align="left" colspan="1" rowspan="1">0.92</td>
<td align="left" colspan="1" rowspan="1">0.34</td>
<td align="left" colspan="1" rowspan="1">7.16</td>
<td align="left" colspan="1" rowspan="1">2.52</td>
<td align="left" colspan="1" rowspan="1">1.28–4.98</td>
<td align="left" colspan="1" rowspan="1">0.007<sup>b</sup>
</td>
</tr>
<tr><td align="left" colspan="8" rowspan="1">Season (reference: spring)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Winter</td>
<td align="left" colspan="1" rowspan="1">4.01</td>
<td align="left" colspan="1" rowspan="1">1.80</td>
<td align="left" colspan="1" rowspan="1">0.63</td>
<td align="left" colspan="1" rowspan="1">8.08</td>
<td align="left" colspan="1" rowspan="1">6.08</td>
<td align="left" colspan="1" rowspan="1">2.75–16.13</td>
<td align="left" colspan="1" rowspan="1">0.004<sup>b</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Summer</td>
<td align="left" colspan="1" rowspan="1">2.34</td>
<td align="left" colspan="1" rowspan="1">0.93</td>
<td align="left" colspan="1" rowspan="1">0.70</td>
<td align="left" colspan="1" rowspan="1">1.79</td>
<td align="left" colspan="1" rowspan="1">2.55</td>
<td align="left" colspan="1" rowspan="1">0.64–8.08</td>
<td align="left" colspan="1" rowspan="1">0.18</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Fall</td>
<td align="left" colspan="1" rowspan="1">2.53</td>
<td align="left" colspan="1" rowspan="1">1.02</td>
<td align="left" colspan="1" rowspan="1">0.64</td>
<td align="left" colspan="1" rowspan="1">2.53</td>
<td align="left" colspan="1" rowspan="1">2.79</td>
<td align="left" colspan="1" rowspan="1">0.78–9.90</td>
<td align="left" colspan="1" rowspan="1">0.11</td>
</tr>
<tr><td align="left" colspan="8" rowspan="1">Physiological primary site of infection (reference: urinary tract)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Respiratory tract</td>
<td align="left" colspan="1" rowspan="1">4.40</td>
<td align="left" colspan="1" rowspan="1">0.91</td>
<td align="left" colspan="1" rowspan="1">0.44</td>
<td align="left" colspan="1" rowspan="1">4.20</td>
<td align="left" colspan="1" rowspan="1">2.49</td>
<td align="left" colspan="1" rowspan="1">1.04–5.97</td>
<td align="left" colspan="1" rowspan="1">0.04<sup>b</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Bloodstream</td>
<td align="left" colspan="1" rowspan="1">2.20</td>
<td align="left" colspan="1" rowspan="1">1.43</td>
<td align="left" colspan="1" rowspan="1">0.80</td>
<td align="left" colspan="1" rowspan="1">3.21</td>
<td align="left" colspan="1" rowspan="1">4.21</td>
<td align="left" colspan="1" rowspan="1">0.87–20.26</td>
<td align="left" colspan="1" rowspan="1">0.07</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p55">
<p><em>AOR</em> adjusted odds ratio, <em>B</em> coefficient for the constant in the null model, <em>CI</em> confidence interval, <em>SE</em> standard error, <em>UOR</em> unadjusted odds ratio, <em>Wald</em> Wald chi-square test that tests the null hypothesis</p>
<p><sup>a</sup>Binary logistic regression using backward stepwise analysis</p>
<p><sup>b</sup>Statistically significant (𝑃 &lt; 0.05)</p>
</div></div></section></section></section><section id="Sec12"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par36">The emergence of DTR <em>P. aeruginosa</em> infections presents a significant clinical challenge due to limited treatment options, poor outcomes, and their association with high morbidity and mortality. DTR <em>P. aeruginosa</em> isolates are resistant to all first-line antibiotics, necessitating the use of less effective or more toxic reserve antibiotics [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. This study investigated the incidence of DTR <em>P. aeruginosa</em> and its associated risk factors in Lebanese hospitals, aiming to contribute to the global understanding of this challenging pathogen.</p>
<p id="Par37">The current study revealed incidence of 15.3% of DTR <em>P. aeruginosa</em> infections among hospitalized patients. This rate is notably higher when compared to global trends reported in various studies. Wise et al. investigated global trends in DTR among clinical isolates of Gram-negative priority pathogens collected by the Antimicrobial Testing Leadership and Surveillance (ATLAS) program from 2018 to 2022. Among these were 30,504 <em>P. aeruginosa</em> isolates collected by 157 medical centers in 49 countries. The DTR <em>P. aeruginosa</em> rates ranged from 6% in North America to 12% in Latin America. In the Middle East and Africa region, DTR <em>P. aeruginosa</em> rate ranged between 8 and 10% from 2018 to 2022 [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. A previous study conducted on collected clinical isolates from the Middle Eastern and African countries between 2015 and 2018 reported DTR <em>P. aeruginosa</em> rates of 5.2–7.4% [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. This indicates a substantial increase in the DTR rates in the region over time. Additionally, the prevalence of DTR <em>P. aeruginosa</em> bloodstream infections in a retrospective single-center study conducted in Italy from 2013 to 2016 was 7.7% [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Another retrospective study conducted in a tertiary care hospital in Singapore, which reviewed laboratory antimicrobial susceptibility testing (AST) data between 2019 and 2021, detected a DTR <em>P. aeruginosa</em> rate to be 3.07% out of 4,715 isolates [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. The regional differences in DTR rates are often due to the varying incidence of enzyme-based resistance mechanisms. When benchmarking the DTR <em>P. aeruginosa</em> rates in Lebanon against these reported global rates, it is evident that the rate in Lebanon is the highest.</p>
<p id="Par38">The rate of CRPA in this study was notably high, with approximately one-third of the isolates (~ 30%) exhibiting resistance. These findings are consistent with the data from a national multicenter study conducted in 2015 and 2016, which included clinical isolates from 13 Lebanese hospitals and reflected Lebanon’s antimicrobial susceptibility landscape. This national study reported a CRPA rate of 30%, with individual hospitals showing rates ranging from 5 to 45% [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. Additionally, the resistance rate of <em>P. aeruginosa</em> to imipenem showed a significant increase, rising from 27% between 2011 and 2013 to 30% between 2015 and 2016 (<em>P</em> = 0.001) [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>, <a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. Additionally, a multicenter national study conducted among three hospitals in northern Lebanon reported the prevalence of CRPA between 2015 and 2019 to be 15% (155/1,034 isolates) [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. A recent retrospective observational study conducted in a Jordanian academic hospital between 2021 and 2022 detected a prevalence rate of CRPA at 41.9% [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. In comparison, a recent study investigating global trends of AMR among 30,504 clinical isolates of <em>P. aeruginosa</em> reported high CRPA rates, ranging from 19% in the Asia Pacific region to 30% in Latin America between 2018 and 2022. Interestingly, this global study found that the CRPA trend in the Middle East and Africa region significantly decreased from 28% in 2018 to 22.4% in 2022 (<em>P</em> &lt; 0.01) [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>].</p>
<p id="Par39">While the CRPA rate in Lebanon remains consistently high at around 30%, the global trends show variation, with some regions experiencing higher rates and others, like the Middle East and Africa, witnessing a decline. The discrepancies in CRPA rates observed across different studies can be attributed to several factors, including variations in study design, geographic and regional differences, resistance mechanisms, the time frame of the studies, patient populations, healthcare infrastructure, and infection control practices. In the context of Lebanon—a low-income country currently grappling with multifaceted crises—the CRPA rate has remained consistently high. This suggests that Lebanon may be facing significant challenges with AMR, potentially due to limited healthcare resources, the absence of a robust national surveillance program, widespread and unregulated antibiotic use, and inadequate infection control practices [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>, <a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>].</p>
<p id="Par40">These challenges are further compounded by the fact that Lebanon currently lacks a robust AMR surveillance system, and existing data are fragmented, retrospective, and primarily limited to a few tertiary care centers [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Although steps have been taken, such as joining the WHO’s Global Antimicrobial Resistance Surveillance System (GLASS) and drafting a National Action Plan (NAP), implementation has been hindered by political instability, inadequate infrastructure, and insufficient funding [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. These gaps in antimicrobial stewardship (AMS) mirror challenges faced by other low- and middle-income countries (LMICs). For instance, recent studies from tertiary care hospitals in Pakistan reported poor adherence to the CDC’s Core Elements of Antibiotic Stewardship, particularly in the areas of tracking and reporting antibiotic use, as well as clinician and patient education [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>, <a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. These findings highlight the global difficulty of optimizing antibiotic use, especially in resource-limited settings where AMS programs remain underdeveloped [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>–<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>].</p>
<p id="Par41">The multivariate regression analysis identified three main risk factors significantly associated with the ‎acquisition of DTR <em>P. aeruginosa</em> infections. Notably, the winter season was significantly associated with DTR <em>P. aeruginosa</em> infections compared to the summer season. This finding aligns with a retrospective observational study conducted in China, which identified seasonality as a risk factor for acquiring CRPA. In that study, isolates collected during the winter were more likely to be carbapenem-resistant than those collected during the summer [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Similarly, another retrospective observational cohort study identified that winter season as a risk factor for the development of nosocomial pneumonia caused by MDR bacteria [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. However, contrasting findings were reported by Kito et al., who investigated the seasonal variation in the prevalence of Gram-negative bacilli. They found that the prevalence of <em>P. aeruginosa</em> was highest during the summer season (<em>P</em> &lt; 0.01) and detected a significant positive correlation between monthly temperature and humidity and the frequency of <em>P. aeruginosa</em> isolation from sputum specimens (<em>P</em> &lt; 0.001) [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. <em>P. aeruginosa</em> typically thrives at temperatures around 37 °C and in humid environments [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>].</p>
<p id="Par42">To the best of our knowledge, this study is the first to identify the winter season as a predictor of DTR <em>P. aeruginosa</em> infections. The seasonal effect on DTR <em>P. aeruginosa</em> is not well understood, but it may be influenced by several factors. During winter, the outbreak of respiratory infections and the increased use or misuse of antibiotics can select for resistant strains, contributing to a higher prevalence of AMR. Additionally, indoor conditions in healthcare settings, such as reduced ventilation and indoor heating, may create environments where the bacteria can persist and spread. The strains that become resistant to antibiotics may exhibit different seasonal dynamics, thriving in these winter-specific conditions. The surge in hospital admissions during this time may further elevate the risk of hospital-acquired infections [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>, <a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. Further research is needed to understand the underlying mechanisms and to reconcile these findings with existing knowledge.</p>
<p id="Par43">This study found that infections acquired in the ICU were 2.5 times more likely to be associated with DTR strains compared to those acquired in other settings. Similarly, previous studies have also recognized ICU stay as an independent risk factor for infection with MDR <em>P. aeruginosa</em> [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. For instance, a systematic review and meta-analysis identified ICU stays—whether during the current infection episode or prior—as a significant predictor of acquiring MDR or XDR <em>P. aeruginosa</em>, with an AOR of 2.2 [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. The increased risk of acquiring DTR strains during an ICU stay can be attributed to several key factors. First, the higher severity of illnesses in ICU patients often necessitates more aggressive treatments, including the use of broad-spectrum antibiotics, which can promote the selection of resistant strains. Additionally, the frequent use of invasive medical devices provides entry points for bacteria and facilitates the development of biofilms, where resistant bacteria can thrive. The ICU environment itself, with its high density of critically ill patients and the intensive use of antibiotics, creates a breeding ground for MDR pathogens, contributing to their emergence and spread among patients [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. These findings emphasize the need for stringent infection control measures in the ICU, including rigorous protocols among healthcare practitioners, to prevent the acquisition and spread of resistant strains. Additionally, they highlight the critical importance of careful antibiotic selection and stewardship in hospital settings to minimize the development of resistance.</p>
<p id="Par44">This study found that respiratory tract infections were more likely to be associated with the acquisition of DTR <em>P. aeruginosa</em>. This finding is consistent with previous research indicating that the respiratory tract is the most common source of MDR <em>P. aeruginosa</em> infections, accounting for 60.3% of cases [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. <em>P. aeruginosa</em> frequently colonizes the tracheobronchial tract, particularly in patients with chronic lung conditions such as cystic fibrosis, COPD, and bronchiectasis. These patients often have a reduced ability to clear respiratory secretions, weakened natural production of antibacterial peptides, and compromised immune defenses, all of which promote bacterial colonization and resistance [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Moreover, <em>P. aeruginosa</em> is among the leading pathogens in healthcare-associated respiratory infections and has developed resistance to multiple drug classes [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. Several risk factors contribute to DTR <em>P. aeruginosa</em> respiratory infections, including prior antibiotic use, underlying lung conditions, previous corticosteroid use, immunosuppression, biofilm formation on mucosal surfaces of the respiratory tract and medical devices like ventilators and endotracheal tubes, and cross-transmission of resistant strains among patients [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. Based on these findings, it is essential to promptly screen and diagnose high-risk patients with respiratory tract infections for potential DTR <em>P. aeruginosa</em> to initiate timely and appropriate antimicrobial therapy. Additionally, implementing strict infection control measures in hospital settings, including reducing the use of invasive medical devices and preventing cross-transmission of resistant pathogens, is crucial.</p>
<section id="Sec13"><h3 class="pmc_sec_title">Study limitations</h3>
<p id="Par45">The current study has several limitations that must be acknowledged. First, the retrospective design inherently limited our ability to establish causal relationships between identified risk factors and DTR <em>P. aeruginosa</em> infections. While we employed multivariate logistic regression to adjust for potential confounders, the absence of a prospective framework introduced ambiguity in the temporality of exposure and outcome. Additionally, the lack of a control group further restricted our capacity to verify associations and control for all sources of bias.</p>
<p id="Par46">Second, the exclusive reliance on medical records for data retrieval may have resulted in missing or incomplete vital information not documented in patient files, which could have compromised the depth of our analysis and increased the risk of recall bias.</p>
<p id="Par47">Third, the study’s focus on four tertiary care centers in Beirut introduces a geographic limitation, raising concerns about the generalizability of the incidence estimates to other hospitals across Lebanon.</p>
<p id="Par48">Fourth, the exclusion of pediatric patients limits the generalizability of our findings to adult populations only, as risk factors may differ significantly in children.</p>
<p id="Par49">Fifth, by including only the first infection episode per patient and excluding recurrent, polymicrobial, and co-infections, the study may have introduced a bias toward less complex cases. This approach could have overlooked the multifaceted nature of infections commonly encountered in clinical practice, thereby limiting the generalizability of the findings.</p>
<p id="Par50">Finally, the lack of documentation of molecular typing data in the patients’ medical charts restricted our ability to identify specific resistant enzymes, determine the exact mechanisms of resistance, and accurately assess resistance rates.</p>
<p id="Par51">To address these limitations, future research should involve prospective, multicenter cohort studies conducted over several years, incorporating standardized data collection methods and molecular characterization of isolates. Such studies would offer a more comprehensive estimate of the national incidence of DTR <em>P. aeruginosa</em> infections, allow for effective tracking of resistance trends, and enhance control of confounding factors while more reliably identifying associated risk factors.</p></section></section><section id="Sec14"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par52">The incidence of DTR <em>P. aeruginosa</em> in Lebanese hospitals is substantial compared to the global rates and poses a significant challenge to effective treatment. Therefore, urgent and coordinated measures are required to prevent and manage the spread of DTR <em>P. aeruginosa</em> infections. Strengthening hospital-based AMS and infection prevention and control programs is essential, alongside implementing community-based initiatives to promote the rational use of antibiotics.</p>
<p id="Par53">At the policy level, addressing AMR in Lebanon requires formally integrating it into the national health agenda, supported by a dedicated budget and sustainable infrastructure. A nationwide AMR surveillance system should be established to generate real-time, high-quality data to guide evidence-based interventions. Additionally, regulatory oversight on antibiotic prescribing and infection control practices must be enforced. The development and dissemination of national treatment guidelines tailored to local susceptibility patterns are also vital to ensure consistent and effective clinical decision-making.</p>
<p id="Par54">Future research should focus on assessing both the implementation and effectiveness of AMS interventions, exploring molecular mechanisms of resistance, and monitoring resistance patterns through well-designed multicenter longitudinal studies.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>None.</p></section><section id="notes1"><h2 class="pmc_sec_title">Authors’ contributions</h2>
<p>The authors confirm their contribution to the paper as follows: study conception and design: RI; data collection: RI; analysis and interpretation of results: RI; draft manuscript preparation: RI, HR, PS, CD, and MH; manuscript copy-editing: HMJK, TLM, and AEL. All authors reviewed the results and approved the final version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The dataset discussed in this article is accessible only upon reasonable request due to the presence of confidential information. To request access to the datasets, please contact the first author at r.itani@bau.edu.lb.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par55">The study was designed and executed in adherence to the World Medical Association Declaration of Helsinki guidelines [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. The study protocol was approved by the institutional review board (IRB) at Beirut Arab University (approval code: 2023-H-0089-P-R-0532). Furthermore, ethical approvals were obtained from the IRBs and ethical committees of the participating hospitals: first hospital (approval code: 2023-IRB-012), second hospital (approval code: 8785/AM/T/BDM/Classification 30350/1), third hospital (approval code: 6/2023), and fourth hospital (approval code: HOP-2023-006). Data collection involved a comprehensive review of de-identified and anonymized medical records, with no direct patient contact or follow-up. The IRBs and ethical committees of the participating hospitals granted a waiver for patient’s informed consent due to the study’s retrospective observational design, which involved data collection post-discharge and ensured that no patient identifiers were accessed. This approach preserved patient privacy and adhered to ethical standards for such observational research.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par56">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par57">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Spagnolo Amaria S, Marina, Cristina ML. Pseudomonas aeruginosa in the healthcare facility setting. Reviews Med Microbiol. 2021;32(3):169–75.</cite> [<a href="https://scholar.google.com/scholar_lookup?Spagnolo%20Amaria%20S,%20Marina,%20Cristina%20ML.%20Pseudomonas%20aeruginosa%20in%20the%20healthcare%20facility%20setting.%20Reviews%20Med%20Microbiol.%202021;32(3):169%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Frem JA, Doumat G, Kazma J, Gharamti A, Kanj SS, Abou Fayad AG, et al. Clinical predictors of mortality in patients with Pseudomonas aeruginosa infection. PLoS ONE. 2023;18(4):e0282276.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0282276" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10146515/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37115776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Frem%20JA,%20Doumat%20G,%20Kazma%20J,%20Gharamti%20A,%20Kanj%20SS,%20Abou%20Fayad%20AG,%20et%20al.%20Clinical%20predictors%20of%20mortality%20in%20patients%20with%20Pseudomonas%20aeruginosa%20infection.%20PLoS%20ONE.%202023;18(4):e0282276." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Riccobene T, Ye G, Lock J, Yu KC, Ai C, Gregory S, et al. Outcomes of inadequate empiric therapy and timing of newer antibacterial therapy in hospitalized adults with culture-positive enterobacterales and Pseudomonas aeruginosa: a multicenter analysis. BMC Infect Dis. 2024;24(1):810.
</cite> [<a href="https://doi.org/10.1186/s12879-024-09700-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11316305/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39123114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Riccobene%20T,%20Ye%20G,%20Lock%20J,%20Yu%20KC,%20Ai%20C,%20Gregory%20S,%20et%20al.%20Outcomes%20of%20inadequate%20empiric%20therapy%20and%20timing%20of%20newer%20antibacterial%20therapy%20in%20hospitalized%20adults%20with%20culture-positive%20enterobacterales%20and%20Pseudomonas%20aeruginosa:%20a%20multicenter%20analysis.%20BMC%20Infect%20Dis.%202024;24(1):810." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis. 2003;37(6):745–51.
</cite> [<a href="https://doi.org/10.1086/377200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12955633/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kang%20CI,%20Kim%20SH,%20Kim%20HB,%20Park%20SW,%20Choe%20YJ,%20Oh%20MD,%20et%20al.%20Pseudomonas%20aeruginosa%20bacteremia:%20risk%20factors%20for%20mortality%20and%20influence%20of%20delayed%20receipt%20of%20effective%20antimicrobial%20therapy%20on%20clinical%20outcome.%20Clin%20Infect%20Dis.%202003;37(6):745%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Papadimitriou-Olivgeris M, Senn L, Jacot D, Guery B. Predictors of mortality of Pseudomonas aeruginosa bacteraemia and the role of infectious diseases consultation and source control; a retrospective cohort study. Infection. 2025;53(1):117–24.
</cite> [<a href="https://doi.org/10.1007/s15010-024-02326-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11825531/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38900392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Papadimitriou-Olivgeris%20M,%20Senn%20L,%20Jacot%20D,%20Guery%20B.%20Predictors%20of%20mortality%20of%20Pseudomonas%20aeruginosa%20bacteraemia%20and%20the%20role%20of%20infectious%20diseases%20consultation%20and%20source%20control;%20a%20retrospective%20cohort%20study.%20Infection.%202025;53(1):117%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Mitchell E, Pearce M, Roberts A, Newton J. Predictive factors of in-hospital mortality in patients with laboratory-confirmed Escherichia coli, Klebsiella species or Pseudomonas aeruginosa bloodstream infections. PLoS ONE. 2021;16(11):e0259305.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0259305" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8562814/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34727130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mitchell%20E,%20Pearce%20M,%20Roberts%20A,%20Newton%20J.%20Predictive%20factors%20of%20in-hospital%20mortality%20in%20patients%20with%20laboratory-confirmed%20Escherichia%20coli,%20Klebsiella%20species%20or%20Pseudomonas%20aeruginosa%20bloodstream%20infections.%20PLoS%20ONE.%202021;16(11):e0259305." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Ioannou P, Alexakis K, Maraki S, Kofteridis DP. Pseudomonas bacteremia in a tertiary hospital and factors associated with mortality. Antibiot (Basel). 2023;12(4):670.</cite> [<a href="https://doi.org/10.3390/antibiotics12040670" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10135004/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37107032/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ioannou%20P,%20Alexakis%20K,%20Maraki%20S,%20Kofteridis%20DP.%20Pseudomonas%20bacteremia%20in%20a%20tertiary%20hospital%20and%20factors%20associated%20with%20mortality.%20Antibiot%20(Basel).%202023;12(4):670." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Context. 2018;7:212527.
</cite> [<a href="https://doi.org/10.7573/dic.212527" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5978525/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29872449/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bassetti%20M,%20Vena%20A,%20Croxatto%20A,%20Righi%20E,%20Guery%20B.%20How%20to%20manage%20Pseudomonas%20aeruginosa%20infections.%20Drugs%20Context.%202018;7:212527." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Liu Q, Li X, Li W, Du X, He JQ, Tao C, et al. Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis. Sci Rep. 2015;5:11715.
</cite> [<a href="https://doi.org/10.1038/srep11715" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4479982/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26108476/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Q,%20Li%20X,%20Li%20W,%20Du%20X,%20He%20JQ,%20Tao%20C,%20et%20al.%20Influence%20of%20carbapenem%20resistance%20on%20mortality%20of%20patients%20with%20Pseudomonas%20aeruginosa%20infection:%20a%20meta-analysis.%20Sci%20Rep.%202015;5:11715." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Kunz Coyne AJ, El Ghali A, Holger D, Rebold N, Rybak MJ. Therapeutic strategies for emerging Multidrug-Resistant Pseudomonas aeruginosa. Infect Dis Ther. 2022;11(2):661–82.
</cite> [<a href="https://doi.org/10.1007/s40121-022-00591-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8960490/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35150435/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kunz%20Coyne%20AJ,%20El%20Ghali%20A,%20Holger%20D,%20Rebold%20N,%20Rybak%20MJ.%20Therapeutic%20strategies%20for%20emerging%20Multidrug-Resistant%20Pseudomonas%20aeruginosa.%20Infect%20Dis%20Ther.%202022;11(2):661%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Giannella M, Bussini L, Pascale R, Bartoletti M, Malagrinò M, Pancaldi L, et al. Prognostic utility of the new definition of Difficult-to-Treat resistance among patients with Gram-Negative bloodstream infections. Open Forum Infect Dis. 2019;6(12):ofz505.
</cite> [<a href="https://doi.org/10.1093/ofid/ofz505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6916520/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31858018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Giannella%20M,%20Bussini%20L,%20Pascale%20R,%20Bartoletti%20M,%20Malagrin%C3%B2%20M,%20Pancaldi%20L,%20et%20al.%20Prognostic%20utility%20of%20the%20new%20definition%20of%20Difficult-to-Treat%20resistance%20among%20patients%20with%20Gram-Negative%20bloodstream%20infections.%20Open%20Forum%20Infect%20Dis.%202019;6(12):ofz505." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>World Health Organization. WHO. 2017. WHO publishes list of bacteria for which new antibiotics are urgently needed. Available from: <a href="https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed</a>. Cited 2024 Feb 29.</cite>
</li>
<li id="CR13">
<span class="label">13.</span><cite>Tabak YP, Merchant S, Ye G, Vankeepuram L, Gupta V, Kurtz SG, et al. Incremental clinical and economic burden of suspected respiratory infections due to multi-drug-resistant Pseudomonas aeruginosa in the united States. J Hosp Infect. 2019;103(2):134–41.
</cite> [<a href="https://doi.org/10.1016/j.jhin.2019.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31228511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tabak%20YP,%20Merchant%20S,%20Ye%20G,%20Vankeepuram%20L,%20Gupta%20V,%20Kurtz%20SG,%20et%20al.%20Incremental%20clinical%20and%20economic%20burden%20of%20suspected%20respiratory%20infections%20due%20to%20multi-drug-resistant%20Pseudomonas%20aeruginosa%20in%20the%20united%20States.%20J%20Hosp%20Infect.%202019;103(2):134%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Vidal-Cortés P, Campos-Fernández S, Cuenca-Fito E, Del Río-Carbajo L, Fernández-Ugidos P, López-Ciudad VJ, et al. Difficult-to-Treat Pseudomonas aeruginosa infections in critically ill patients: A comprehensive review and treatment proposal. Antibiot (Basel). 2025;14(2):178.</cite> [<a href="https://doi.org/10.3390/antibiotics14020178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11851922/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40001421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vidal-Cort%C3%A9s%20P,%20Campos-Fern%C3%A1ndez%20S,%20Cuenca-Fito%20E,%20Del%20R%C3%ADo-Carbajo%20L,%20Fern%C3%A1ndez-Ugidos%20P,%20L%C3%B3pez-Ciudad%20VJ,%20et%20al.%20Difficult-to-Treat%20Pseudomonas%20aeruginosa%20infections%20in%20critically%20ill%20patients:%20A%20comprehensive%20review%20and%20treatment%20proposal.%20Antibiot%20(Basel).%202025;14(2):178." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, et al. Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. Lancet Microbe. 2023;4(3):e159–70.
</cite> [<a href="https://doi.org/10.1016/S2666-5247(22)00329-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10016089/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36774938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Reyes%20J,%20Komarow%20L,%20Chen%20L,%20Ge%20L,%20Hanson%20BM,%20Cober%20E,%20et%20al.%20Global%20epidemiology%20and%20clinical%20outcomes%20of%20carbapenem-resistant%20Pseudomonas%20aeruginosa%20and%20associated%20carbapenemases%20(POP):%20a%20prospective%20cohort%20study.%20Lancet%20Microbe.%202023;4(3):e159%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Matta R, Hallit S, Hallit R, Bawab W, Rogues AM, Salameh P. Epidemiology and Microbiological profile comparison between community and hospital acquired infections: A multicenter retrospective study in Lebanon. J Infect Public Health. 2018;11(3):405–11.
</cite> [<a href="https://doi.org/10.1016/j.jiph.2017.09.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28970096/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Matta%20R,%20Hallit%20S,%20Hallit%20R,%20Bawab%20W,%20Rogues%20AM,%20Salameh%20P.%20Epidemiology%20and%20Microbiological%20profile%20comparison%20between%20community%20and%20hospital%20acquired%20infections:%20A%20multicenter%20retrospective%20study%20in%20Lebanon.%20J%20Infect%20Public%20Health.%202018;11(3):405%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Nasr J, Abdessamad H, Mina J, Haykal T, Jamil Y, Abboud E. The epidemiology of gram-negative bacteremia in lebanon: a study in four hospitals. Ann Clin Microbiol Antimicrob. 2024;23(1):90.
</cite> [<a href="https://doi.org/10.1186/s12941-024-00740-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11465513/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39385237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nasr%20J,%20Abdessamad%20H,%20Mina%20J,%20Haykal%20T,%20Jamil%20Y,%20Abboud%20E.%20The%20epidemiology%20of%20gram-negative%20bacteremia%20in%20lebanon:%20a%20study%20in%20four%20hospitals.%20Ann%20Clin%20Microbiol%20Antimicrob.%202024;23(1):90." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Yaghi J, Fattouh N, Akkawi C, El Chamy L, Maroun RG, Khalil G. Unusually high prevalence of cosecretion of ambler class A and B carbapenemases and nonenzymatic mechanisms in Multidrug-Resistant clinical isolates of Pseudomonas aeruginosa in Lebanon. Microb Drug Resist. 2020;26(2):150–59.
</cite> [<a href="https://doi.org/10.1089/mdr.2019.0040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31424353/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yaghi%20J,%20Fattouh%20N,%20Akkawi%20C,%20El%20Chamy%20L,%20Maroun%20RG,%20Khalil%20G.%20Unusually%20high%20prevalence%20of%20cosecretion%20of%20ambler%20class%20A%20and%20B%20carbapenemases%20and%20nonenzymatic%20mechanisms%20in%20Multidrug-Resistant%20clinical%20isolates%20of%20Pseudomonas%20aeruginosa%20in%20Lebanon.%20Microb%20Drug%20Resist.%202020;26(2):150%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.
</cite> [<a href="https://doi.org/10.1111/j.1469-0691.2011.03570.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21793988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Magiorakos%20AP,%20Srinivasan%20A,%20Carey%20RB,%20Carmeli%20Y,%20Falagas%20ME,%20Giske%20CG,%20et%20al.%20Multidrug-resistant,%20extensively%20drug-resistant%20and%20pandrug-resistant%20bacteria:%20an%20international%20expert%20proposal%20for%20interim%20standard%20definitions%20for%20acquired%20resistance.%20Clin%20Microbiol%20Infect.%202012;18(3):268%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Cosentino F, Viale P, Giannella M. MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa? Curr Opin Infect Dis. 2023;36(6):564–71.
</cite> [<a href="https://doi.org/10.1097/QCO.0000000000000966" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10836784/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37930070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cosentino%20F,%20Viale%20P,%20Giannella%20M.%20MDR/XDR/PDR%20or%20DTR?%20Which%20definition%20best%20fits%20the%20resistance%20profile%20of%20Pseudomonas%20aeruginosa?%20Curr%20Opin%20Infect%20Dis.%202023;36(6):564%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Kadri SS, Adjemian J, Lai YL, Spaulding AB, Ricotta E, Prevots DR, et al. Difficult-to-Treat resistance in Gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all First-line agents. Clin Infect Dis. 2018;67(12):1803–14.
</cite> [<a href="https://doi.org/10.1093/cid/ciy378" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6260171/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30052813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kadri%20SS,%20Adjemian%20J,%20Lai%20YL,%20Spaulding%20AB,%20Ricotta%20E,%20Prevots%20DR,%20et%20al.%20Difficult-to-Treat%20resistance%20in%20Gram-negative%20bacteremia%20at%20173%20US%20hospitals:%20retrospective%20cohort%20analysis%20of%20prevalence,%20predictors,%20and%20outcome%20of%20resistance%20to%20all%20First-line%20agents.%20Clin%20Infect%20Dis.%202018;67(12):1803%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Karruli A, Catalini C, D’Amore C, Foglia F, Mari F, Harxhi A, et al. Evidence-Based treatment of Pseudomonas aeruginosa infections: A critical reappraisal. Antibiot (Basel). 2023;12(2):399.</cite> [<a href="https://doi.org/10.3390/antibiotics12020399" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9952410/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36830309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Karruli%20A,%20Catalini%20C,%20D%E2%80%99Amore%20C,%20Foglia%20F,%20Mari%20F,%20Harxhi%20A,%20et%20al.%20Evidence-Based%20treatment%20of%20Pseudomonas%20aeruginosa%20infections:%20A%20critical%20reappraisal.%20Antibiot%20(Basel).%202023;12(2):399." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Rello J, Allegri C, Rodriguez A, Vidaur L, Sirgo G, Gomez F, et al. Risk factors for ventilator-associated pneumonia by Pseudomonas aeruginosa in presence of recent antibiotic exposure. Anesthesiology. 2006;105(4):709–14.
</cite> [<a href="https://doi.org/10.1097/00000542-200610000-00016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17006069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rello%20J,%20Allegri%20C,%20Rodriguez%20A,%20Vidaur%20L,%20Sirgo%20G,%20Gomez%20F,%20et%20al.%20Risk%20factors%20for%20ventilator-associated%20pneumonia%20by%20Pseudomonas%20aeruginosa%20in%20presence%20of%20recent%20antibiotic%20exposure.%20Anesthesiology.%202006;105(4):709%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Karajeh J, Sapozhnikov J, Adams J, Albarillo FS, Santarossa M, Hoff BM. 2585. Identification of Risk Factors for Pseudomonas aeruginosa in Patients with Community-Acquired Pneumonia. Open Forum Infect Dis. 2023;10(Supplement_2):ofad500.2200.</cite>
</li>
<li id="CR25">
<span class="label">25.</span><cite>Trinh TD, Zasowski EJ, Claeys KC, Lagnf AM, Kidambi S, Davis SL, et al. Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: prevalence and risk factors. Diagn Microbiol Infect Dis. 2017;89(1):61–6.
</cite> [<a href="https://doi.org/10.1016/j.diagmicrobio.2017.06.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28716451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Trinh%20TD,%20Zasowski%20EJ,%20Claeys%20KC,%20Lagnf%20AM,%20Kidambi%20S,%20Davis%20SL,%20et%20al.%20Multidrug-resistant%20Pseudomonas%20aeruginosa%20lower%20respiratory%20tract%20infections%20in%20the%20intensive%20care%20unit:%20prevalence%20and%20risk%20factors.%20Diagn%20Microbiol%20Infect%20Dis.%202017;89(1):61%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Kito Y, Kuwabara K, Ono K, Kato K, Yokoi T, Horiguchi K, et al. Seasonal variation in the prevalence of Gram-negative bacilli in sputum and urine specimens from outpatients and inpatients. Fujita Med J. 2022;8(2):46–51.
</cite> [<a href="https://doi.org/10.20407/fmj.2021-003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9069267/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35520292/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kito%20Y,%20Kuwabara%20K,%20Ono%20K,%20Kato%20K,%20Yokoi%20T,%20Horiguchi%20K,%20et%20al.%20Seasonal%20variation%20in%20the%20prevalence%20of%20Gram-negative%20bacilli%20in%20sputum%20and%20urine%20specimens%20from%20outpatients%20and%20inpatients.%20Fujita%20Med%20J.%202022;8(2):46%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Labaste F, Grossac J, Bounes FV, Conil JM, Ruiz S, Seguin T, et al. Risk factors for acquisition of carbapenem-resistance during treatment with carbapenem in the intensive care unit: a prospective study. Eur J Clin Microbiol Infect Dis. 2019;38(11):2077–85.
</cite> [<a href="https://doi.org/10.1007/s10096-019-03644-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6800833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31482416/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Labaste%20F,%20Grossac%20J,%20Bounes%20FV,%20Conil%20JM,%20Ruiz%20S,%20Seguin%20T,%20et%20al.%20Risk%20factors%20for%20acquisition%20of%20carbapenem-resistance%20during%20treatment%20with%20carbapenem%20in%20the%20intensive%20care%20unit:%20a%20prospective%20study.%20Eur%20J%20Clin%20Microbiol%20Infect%20Dis.%202019;38(11):2077%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Seligman R, Ramos-Lima LF, Oliveira Vdo, Sanvicente A, Sartori C, Pacheco J. Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia. Jornal Brasileiro De Pneumologia. 2013;39(3):339–48.
</cite> [<a href="https://doi.org/10.1590/S1806-37132013000300011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4075848/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23857697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Seligman%20R,%20Ramos-Lima%20LF,%20Oliveira%20Vdo,%20Sanvicente%20A,%20Sartori%20C,%20Pacheco%20J.%20Risk%20factors%20for%20infection%20with%20multidrug-resistant%20bacteria%20in%20non-ventilated%20patients%20with%20hospital-acquired%20pneumonia.%20Jornal%20Brasileiro%20De%20Pneumologia.%202013;39(3):339%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Itani R, Khojah HMJ, Karout S, Rahme D, Hammoud L, Awad R, et al. Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon. Antimicrob Resist Infect Control. 2023;12(1):136.
</cite> [<a href="https://doi.org/10.1186/s13756-023-01343-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10685635/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38031181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Itani%20R,%20Khojah%20HMJ,%20Karout%20S,%20Rahme%20D,%20Hammoud%20L,%20Awad%20R,%20et%20al.%20Acinetobacter%20baumannii:%20assessing%20susceptibility%20patterns,%20management%20practices,%20and%20mortality%20predictors%20in%20a%20tertiary%20teaching%20hospital%20in%20Lebanon.%20Antimicrob%20Resist%20Infect%20Control.%202023;12(1):136." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Hu YY, Cao JM, Yang Q, Chen S, Lv HY, Zhou HW, et al. Risk factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang province, China. Emerg Infect Dis. 2019;25(10):1861–7.
</cite> [<a href="https://doi.org/10.3201/eid2510.181699" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6759267/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31538558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20YY,%20Cao%20JM,%20Yang%20Q,%20Chen%20S,%20Lv%20HY,%20Zhou%20HW,%20et%20al.%20Risk%20factors%20for%20Carbapenem-Resistant%20Pseudomonas%20aeruginosa,%20Zhejiang%20province,%20China.%20Emerg%20Infect%20Dis.%202019;25(10):1861%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Leong Q, Chew KL. Drug resistance rates of difficult to treat Pseudomonas aeruginosa isolates to ceftolozane-tazobactam and ceftazidime-avibactam from a tertiary hospital. Singapore Pathology England. 2022;54:966–8.</cite> [<a href="https://doi.org/10.1016/j.pathol.2021.12.298" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35305797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leong%20Q,%20Chew%20KL.%20Drug%20resistance%20rates%20of%20difficult%20to%20treat%20Pseudomonas%20aeruginosa%20isolates%20to%20ceftolozane-tazobactam%20and%20ceftazidime-avibactam%20from%20a%20tertiary%20hospital.%20Singapore%20Pathology%20England.%202022;54:966%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Raman G, Avendano EE, Chan J, Merchant S, Puzniak L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2018;7:79.
</cite> [<a href="https://doi.org/10.1186/s13756-018-0370-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6032536/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29997889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Raman%20G,%20Avendano%20EE,%20Chan%20J,%20Merchant%20S,%20Puzniak%20L.%20Risk%20factors%20for%20hospitalized%20patients%20with%20resistant%20or%20multidrug-resistant%20Pseudomonas%20aeruginosa%20infections:%20a%20systematic%20review%20and%20meta-analysis.%20Antimicrob%20Resist%20Infect%20Control.%202018;7:79." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Monegro AF, Muppidi V, Regunath H, StatPearls P. 2023. Hospital-Acquired Infections. Available from: <a href="https://www.ncbi.nlm.nih.gov/books/NBK441857/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/books/NBK441857/</a>. Cited 2024 Aug 6.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/28722887/" class="usa-link">PubMed</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Alotaibi T, Abuhaimed A, Alshahrani M, Albdelhady A, Almubarak Y, Almasari O. Prevalence of multidrug-resistant acinetobacter baumannii in a critical care setting: A tertiary teaching hospital experience. SAGE Open Med. 2021;9:1–5.</cite> [<a href="https://doi.org/10.1177/20503121211001144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7968016/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33796296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alotaibi%20T,%20Abuhaimed%20A,%20Alshahrani%20M,%20Albdelhady%20A,%20Almubarak%20Y,%20Almasari%20O.%20Prevalence%20of%20multidrug-resistant%20acinetobacter%20baumannii%20in%20a%20critical%20care%20setting:%20A%20tertiary%20teaching%20hospital%20experience.%20SAGE%20Open%20Med.%202021;9:1%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
</cite> [<a href="https://doi.org/10.1016/0021-9681(87)90171-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3558716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Charlson%20ME,%20Pompei%20P,%20Ales%20KL,%20MacKenzie%20CR.%20A%20new%20method%20of%20classifying%20prognostic%20comorbidity%20in%20longitudinal%20studies:%20development%20and%20validation.%20J%20Chronic%20Dis.%201987;40(5):373%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>MD CALC. Charlson Comorbidity Index (CCI).. Available from: <a href="https://www.mdcalc.com/calc/3917/charlson-comorbidity-index-cci" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.mdcalc.com/calc/3917/charlson-comorbidity-index-cci</a>. Cited 2024 Mar 16.</cite>
</li>
<li id="CR37">
<span class="label">37.</span><cite>Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson comorbidity index: A critical review of clinimetric properties. Psychother Psychosom. 2022;91(1):8–35.
</cite> [<a href="https://doi.org/10.1159/000521288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34991091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Charlson%20ME,%20Carrozzino%20D,%20Guidi%20J,%20Patierno%20C.%20Charlson%20comorbidity%20index:%20A%20critical%20review%20of%20clinimetric%20properties.%20Psychother%20Psychosom.%202022;91(1):8%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Yang YS, Lee YT, Huang TW, Sun JR, Kuo SC, Yang CH, et al. Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients? BMC Infect Dis. 2013;13:142.
</cite> [<a href="https://doi.org/10.1186/1471-2334-13-142" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3605360/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23509931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20YS,%20Lee%20YT,%20Huang%20TW,%20Sun%20JR,%20Kuo%20SC,%20Yang%20CH,%20et%20al.%20Acinetobacter%20baumannii%20nosocomial%20pneumonia:%20is%20the%20outcome%20more%20favorable%20in%20non-ventilated%20than%20ventilated%20patients?%20BMC%20Infect%20Dis.%202013;13:142." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Reichman DE, Greenberg JA. Reducing surgical site infections: a review. Rev Obstet Gynecol. 2009;2(4):212–21.
</cite> [<a href="/articles/PMC2812878/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20111657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Reichman%20DE,%20Greenberg%20JA.%20Reducing%20surgical%20site%20infections:%20a%20review.%20Rev%20Obstet%20Gynecol.%202009;2(4):212%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI document M100. Wayne, PA: CLSI. 2023.</cite>
</li>
<li id="CR41">
<span class="label">41.</span><cite>WMA. World medical association declaration of helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.
</cite> [<a href="https://doi.org/10.1001/jama.2013.281053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24141714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?WMA.%20World%20medical%20association%20declaration%20of%20helsinki:%20ethical%20principles%20for%20medical%20research%20involving%20human%20subjects.%20JAMA.%202013;310(20):2191%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Wise MG, Karlowsky JA, Mohamed N, Hermsen ED, Kamat S, Townsend A, et al. Global trends in carbapenem- and difficult-to-treat-resistance among world health organization priority bacterial pathogens: ATLAS surveillance program 2018–2022. J Glob Antimicrob Resist. 2024;37:168–75.
</cite> [<a href="https://doi.org/10.1016/j.jgar.2024.03.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38608936/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wise%20MG,%20Karlowsky%20JA,%20Mohamed%20N,%20Hermsen%20ED,%20Kamat%20S,%20Townsend%20A,%20et%20al.%20Global%20trends%20in%20carbapenem-%20and%20difficult-to-treat-resistance%20among%20world%20health%20organization%20priority%20bacterial%20pathogens:%20ATLAS%20surveillance%20program%202018%E2%80%932022.%20J%20Glob%20Antimicrob%20Resist.%202024;37:168%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Karlowsky JA, Bouchillon SK, El Mahdy Kotb R, Mohamed N, Stone GG, Sahm DF. In vitro activity of ceftazidime/avibactam against clinical isolates of enterobacterales and Pseudomonas aeruginosa from middle Eastern and African countries: ATLAS global surveillance programme 2015–18. JAC Antimicrob Resist. 2021;3(2):dlab067.
</cite> [<a href="https://doi.org/10.1093/jacamr/dlab067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8251253/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34223129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Karlowsky%20JA,%20Bouchillon%20SK,%20El%20Mahdy%20Kotb%20R,%20Mohamed%20N,%20Stone%20GG,%20Sahm%20DF.%20In%20vitro%20activity%20of%20ceftazidime/avibactam%20against%20clinical%20isolates%20of%20enterobacterales%20and%20Pseudomonas%20aeruginosa%20from%20middle%20Eastern%20and%20African%20countries:%20ATLAS%20global%20surveillance%20programme%202015%E2%80%9318.%20JAC%20Antimicrob%20Resist.%202021;3(2):dlab067." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Moghnieh R, Araj GF, Awad L, Daoud Z, Mokhbat JE, Jisr T, et al. A compilation of antimicrobial susceptibility data from a network of 13 Lebanese hospitals reflecting the National situation during 2015–2016. Antimicrob Resist Infect Control. 2019;8:41.
</cite> [<a href="https://doi.org/10.1186/s13756-019-0487-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6381724/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30828445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Moghnieh%20R,%20Araj%20GF,%20Awad%20L,%20Daoud%20Z,%20Mokhbat%20JE,%20Jisr%20T,%20et%20al.%20A%20compilation%20of%20antimicrobial%20susceptibility%20data%20from%20a%20network%20of%2013%20Lebanese%20hospitals%20reflecting%20the%20National%20situation%20during%202015%E2%80%932016.%20Antimicrob%20Resist%20Infect%20Control.%202019;8:41." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Chamoun K, Farah M, Araj G, Daoud Z, Moghnieh R, Salameh P, et al. Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data. Int J Infect Dis. 2016;46:64–70.
</cite> [<a href="https://doi.org/10.1016/j.ijid.2016.03.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26996458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chamoun%20K,%20Farah%20M,%20Araj%20G,%20Daoud%20Z,%20Moghnieh%20R,%20Salameh%20P,%20et%20al.%20Surveillance%20of%20antimicrobial%20resistance%20in%20Lebanese%20hospitals:%20retrospective%20nationwide%20compiled%20data.%20Int%20J%20Infect%20Dis.%202016;46:64%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Rima M, Oueslati S, Dabos L, Daaboul D, Mallat H, Bou Raad E, et al. Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon. Antibiotics. 2022;11:1295.
</cite> [<a href="https://doi.org/10.3390/antibiotics11101295" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9598570/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36289953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rima%20M,%20Oueslati%20S,%20Dabos%20L,%20Daaboul%20D,%20Mallat%20H,%20Bou%20Raad%20E,%20et%20al.%20Prevalence%20and%20Molecular%20Mechanisms%20of%20Carbapenem%20Resistance%20among%20Gram-Negative%20Bacilli%20in%20Three%20Hospitals%20of%20Northern%20Lebanon.%20Antibiotics.%202022;11:1295." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Hammour KA, Abu-farha R, Itani R, Karout S, Allan A, Manaseer Q. The prevalence of carbapenem resistance gram negative pathogens in a tertiary teaching hospital in Jordan. BMC Infect Dis. 2023;23:634–40.
</cite> [<a href="https://doi.org/10.1186/s12879-023-08610-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10523830/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37759305/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hammour%20KA,%20Abu-farha%20R,%20Itani%20R,%20Karout%20S,%20Allan%20A,%20Manaseer%20Q.%20The%20prevalence%20of%20carbapenem%20resistance%20gram%20negative%20pathogens%20in%20a%20tertiary%20teaching%20hospital%20in%20Jordan.%20BMC%20Infect%20Dis.%202023;23:634%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Itani R, Karout S, Khojah H, Abu-Farha R, Mukattash TL, Karout L. Diverging levels of COVID-19 governmental response satisfaction across middle Eastern Arab countries: a multinational study. BMC Public Health. 2022;22(1):893.
</cite> [<a href="https://doi.org/10.1186/s12889-022-13292-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9069218/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35513805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Itani%20R,%20Karout%20S,%20Khojah%20H,%20Abu-Farha%20R,%20Mukattash%20TL,%20Karout%20L.%20Diverging%20levels%20of%20COVID-19%20governmental%20response%20satisfaction%20across%20middle%20Eastern%20Arab%20countries:%20a%20multinational%20study.%20BMC%20Public%20Health.%202022;22(1):893." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Karout S, Khojah HMJ, Itani R, Jaffal F, El-Lakany A. Assessing the pharmaceutical care provision to suspected COVID-19 patients in community pharmacies: a simulated patient study. BMC Health Serv Res. 2022;22(1):467.
</cite> [<a href="https://doi.org/10.1186/s12913-022-07870-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8994087/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35397543/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Karout%20S,%20Khojah%20HMJ,%20Itani%20R,%20Jaffal%20F,%20El-Lakany%20A.%20Assessing%20the%20pharmaceutical%20care%20provision%20to%20suspected%20COVID-19%20patients%20in%20community%20pharmacies:%20a%20simulated%20patient%20study.%20BMC%20Health%20Serv%20Res.%202022;22(1):467." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Raheem M, Anwaar S, Aziz Z, Raja SA, Saif-Ur-Rehman N, Mubarak N. Adherence to the core elements of outpatient antibiotic stewardship: A Cross-Sectional survey in the tertiary care hospitals of punjab, Pakistan. Infect Drug Resist. 2020;13:3833–41.
</cite> [<a href="https://doi.org/10.2147/IDR.S268574" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7602895/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33149628/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Raheem%20M,%20Anwaar%20S,%20Aziz%20Z,%20Raja%20SA,%20Saif-Ur-Rehman%20N,%20Mubarak%20N.%20Adherence%20to%20the%20core%20elements%20of%20outpatient%20antibiotic%20stewardship:%20A%20Cross-Sectional%20survey%20in%20the%20tertiary%20care%20hospitals%20of%20punjab,%20Pakistan.%20Infect%20Drug%20Resist.%202020;13:3833%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Mubarak N, Khan AS, Zahid T, Ijaz UEB, Aziz MM, Khan R, et al. Assessment of adherence to the core elements of hospital antibiotic stewardship programs: A survey of the tertiary care hospitals in punjab, Pakistan. Antibiot (Basel). 2021;10(8):906.</cite> [<a href="https://doi.org/10.3390/antibiotics10080906" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8388777/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34438956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mubarak%20N,%20Khan%20AS,%20Zahid%20T,%20Ijaz%20UEB,%20Aziz%20MM,%20Khan%20R,%20et%20al.%20Assessment%20of%20adherence%20to%20the%20core%20elements%20of%20hospital%20antibiotic%20stewardship%20programs:%20A%20survey%20of%20the%20tertiary%20care%20hospitals%20in%20punjab,%20Pakistan.%20Antibiot%20(Basel).%202021;10(8):906." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Dabbousi AA, Dabboussi F, Hamze M, Osman M, Kassem II. The emergence and dissemination of multidrug resistant Pseudomonas aeruginosa in lebanon: current status and challenges during the economic crisis. Antibiot (Basel). 2022;11(5):687.</cite> [<a href="https://doi.org/10.3390/antibiotics11050687" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9137902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35625331/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dabbousi%20AA,%20Dabboussi%20F,%20Hamze%20M,%20Osman%20M,%20Kassem%20II.%20The%20emergence%20and%20dissemination%20of%20multidrug%20resistant%20Pseudomonas%20aeruginosa%20in%20lebanon:%20current%20status%20and%20challenges%20during%20the%20economic%20crisis.%20Antibiot%20(Basel).%202022;11(5):687." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Iskandar K, Molinier L, Hallit S, Sartelli M, Hardcastle TC, Haque M, et al. Surveillance of antimicrobial resistance in Low- and Middle-Income countries: A scattered picture. Antimicrob Resist Infect Control. 2021;10(1):63.
</cite> [<a href="https://doi.org/10.1186/s13756-021-00931-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8011122/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33789754/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Iskandar%20K,%20Molinier%20L,%20Hallit%20S,%20Sartelli%20M,%20Hardcastle%20TC,%20Haque%20M,%20et%20al.%20Surveillance%20of%20antimicrobial%20resistance%20in%20Low-%20and%20Middle-Income%20countries:%20A%20scattered%20picture.%20Antimicrob%20Resist%20Infect%20Control.%202021;10(1):63." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>World Health Organization. WHO. 2017. Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early Implementation 2016–2017. Available from: <a href="https://cdn.who.int/media/docs/default-source/searo/amr/global-antimicrobial-resistance-surveillance-system-%28glass%29-report-early-implementation-2016-2017.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://cdn.who.int/media/docs/default-source/searo/amr/global-antimicrobial-resistance-surveillance-system-%28glass%29-report-early-implementation-2016-2017.pdf</a>. Cited 2025 Feb 16.</cite>
</li>
<li id="CR55">
<span class="label">55.</span><cite>World Health Organization. WHO. 2020. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: Early Implementation 2020. Available from: <a href="https://iris.who.int/bitstream/handle/10665/332081/9789240005587-eng.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://iris.who.int/bitstream/handle/10665/332081/9789240005587-eng.pdf</a>. Cited 2025 Feb 16.</cite>
</li>
<li id="CR56">
<span class="label">56.</span><cite>World Health Organization. WHO. 2019. Republic of Lebanon, Ministry of Public Health: National Action Plan on Combating Antimicrobial Resistance. Available from: <a href="https://cdn.who.int/media/docs/default-source/antimicrobial-resistance/amr-spc-npm/nap-library/final--lebanese-amr-nap-lebanon-march-2019.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://cdn.who.int/media/docs/default-source/antimicrobial-resistance/amr-spc-npm/nap-library/final--lebanese-amr-nap-lebanon-march-2019.pdf</a>. Cited 2025 Feb 16.</cite>
</li>
<li id="CR57">
<span class="label">57.</span><cite>Martinez EP, Cepeda M, Jovanoska M, Bramer WM, Schoufour J, Glisic M, et al. Seasonality of antimicrobial resistance rates in respiratory bacteria: A systematic review and meta-analysis. PLoS ONE. 2019;14(8):e0221133.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0221133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6695168/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31415656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Martinez%20EP,%20Cepeda%20M,%20Jovanoska%20M,%20Bramer%20WM,%20Schoufour%20J,%20Glisic%20M,%20et%20al.%20Seasonality%20of%20antimicrobial%20resistance%20rates%20in%20respiratory%20bacteria:%20A%20systematic%20review%20and%20meta-analysis.%20PLoS%20ONE.%202019;14(8):e0221133." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Gupta V, Yu KC, Kabler H, Watts JA, Amiche A. Antibiotic resistance patterns and association with the influenza season in the united states: A multicenter evaluation reveals surprising associations between influenza season and resistance in Gram-Negative pathogens. Open Forum Infect Dis. 2022;9(3):ofac039.
</cite> [<a href="https://doi.org/10.1093/ofid/ofac039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8883593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35237702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gupta%20V,%20Yu%20KC,%20Kabler%20H,%20Watts%20JA,%20Amiche%20A.%20Antibiotic%20resistance%20patterns%20and%20association%20with%20the%20influenza%20season%20in%20the%20united%20states:%20A%20multicenter%20evaluation%20reveals%20surprising%20associations%20between%20influenza%20season%20and%20resistance%20in%20Gram-Negative%20pathogens.%20Open%20Forum%20Infect%20Dis.%202022;9(3):ofac039." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Jorgensen SCJ, Trinh TD, Zasowski EJ, Lagnf AM, Bhatia S, Melvin SM, et al. Real-World experience with Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative bacterial infections. Open Forum Infect Dis. 2019;6(12):ofz522.
</cite> [<a href="https://doi.org/10.1093/ofid/ofz522" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6934163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31890725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jorgensen%20SCJ,%20Trinh%20TD,%20Zasowski%20EJ,%20Lagnf%20AM,%20Bhatia%20S,%20Melvin%20SM,%20et%20al.%20Real-World%20experience%20with%20Ceftazidime-Avibactam%20for%20Multidrug-Resistant%20Gram-Negative%20bacterial%20infections.%20Open%20Forum%20Infect%20Dis.%202019;6(12):ofz522." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Pachori P, Gothalwal R, Gandhi P. Emergence of antibiotic resistance Pseudomonas aeruginosa in Icu care unit; a critical review. Genes Dis. 2019;6(2):109–19.
</cite> [<a href="https://doi.org/10.1016/j.gendis.2019.04.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6545445/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31194018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pachori%20P,%20Gothalwal%20R,%20Gandhi%20P.%20Emergence%20of%20antibiotic%20resistance%20Pseudomonas%20aeruginosa%20in%20Icu%20care%20unit;%20a%20critical%20review.%20Genes%20Dis.%202019;6(2):109%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The dataset discussed in this article is accessible only upon reasonable request due to the presence of confidential information. To request access to the datasets, please contact the first author at r.itani@bau.edu.lb.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from BMC Infectious Diseases are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12879-025-11467-4"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12879_2025_Article_11467.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.3 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12366003/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12366003/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366003%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366003/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12366003/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12366003/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40836228/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12366003/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40836228/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12366003/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12366003/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="lRN7KHZVggUfMLR7VJBlwH1JVBzM8IcKJhyALlSD6ipp0R4KRNw7SIvfXT8whsit">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
